<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nicotine replacement therapy versus control for smoking cessation - Hartmann‐Boyce, J - 2018 | Cochrane Library</title> <meta content="Nicotine replacement therapy versus control for smoking cessation - Hartmann‐Boyce, J - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nicotine replacement therapy versus control for smoking cessation - Hartmann‐Boyce, J - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000146.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Nicotine replacement therapy versus control for smoking cessation" name="citation_title"/> <meta content="Jamie Hartmann‐Boyce" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="jamie.hartmann-boyce@phc.ox.ac.uk" name="citation_author_email"/> <meta content="Samantha C Chepkin" name="citation_author"/> <meta content="Cochrane UK" name="citation_author_institution"/> <meta content="Weiyu Ye" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Chris Bullen" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Tim Lancaster" name="citation_author"/> <meta content="King’s College London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD000146.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000146.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Nicotine [administration &amp; dosage]; Nicotinic Agonists [administration &amp; dosage]; Randomized Controlled Trials as Topic; Smoking Cessation [*methods, statistics &amp; numerical data]; Smoking Prevention [*methods, statistics &amp; numerical data]; Tablets; Time Factors; *Tobacco Use Cessation Devices" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000146.pub5&amp;doi=10.1002/14651858.CD000146.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="STpJR8yz";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000146\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000146\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","pl","fr","zh_HANT","hr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000146.pub5",title:"Nicotine replacement therapy versus control for smoking cessation",firstPublishedDate:"May 31, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Tobacco Addiction Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=STpJR8yz&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000146.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000146.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000146.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000146.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000146.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000146.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000146.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000146.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000146.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000146.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>48660 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000146.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0072"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0031"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0032"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0049"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-sec-0065"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/appendices#CD000146-sec-0077"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/table_n/CD000146StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/table_n/CD000146StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nicotine replacement therapy versus control for smoking cessation</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#CD000146-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jamie Hartmann‐Boyce</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#CD000146-cr-0003">Samantha C Chepkin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#CD000146-cr-0004">Weiyu Ye</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#CD000146-cr-0005">Chris Bullen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information#CD000146-cr-0006">Tim Lancaster</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information/en#CD000146-sec-0098">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000146.pub5">https://doi.org/10.1002/14651858.CD000146.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000146-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000146-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000146-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000146-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000146-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000146-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000146-abs-0001" lang="en"> <section id="CD000146-sec-0001"> <h3 class="title" id="CD000146-sec-0001">Background</h3> <p>Nicotine replacement therapy (NRT) aims to temporarily replace much of the nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms, thus easing the transition from cigarette smoking to complete abstinence. </p> </section> <section id="CD000146-sec-0002"> <h3 class="title" id="CD000146-sec-0002">Objectives</h3> <p>To determine the effectiveness and safety of nicotine replacement therapy (NRT), including gum, transdermal patch, intranasal spray and inhaled and oral preparations, for achieving long‐term smoking cessation, compared to placebo or 'no NRT' interventions. </p> </section> <section id="CD000146-sec-0003"> <h3 class="title" id="CD000146-sec-0003">Search methods</h3> <p>We searched the Cochrane Tobacco Addiction Group trials register for papers mentioning 'NRT' or any type of nicotine replacement therapy in the title, abstract or keywords. Date of most recent search is July 2017. </p> </section> <section id="CD000146-sec-0004"> <h3 class="title" id="CD000146-sec-0004">Selection criteria</h3> <p>Randomized trials in people motivated to quit which compared NRT to placebo or to no treatment. We excluded trials that did not report cessation rates, and those with follow‐up of less than six months. We recorded adverse events from included and excluded studies that compared NRT with placebo. Studies comparing different types, durations, and doses of NRT, and studies comparing NRT to other pharmacotherapies, are covered in separate reviews. </p> </section> <section id="CD000146-sec-0005"> <h3 class="title" id="CD000146-sec-0005">Data collection and analysis</h3> <p>Screening, data extraction and 'Risk of bias' assessment followed standard Cochrane methods. The main outcome measure was abstinence from smoking after at least six months of follow‐up. We used the most rigorous definition of abstinence for each trial, and biochemically validated rates if available. We calculated the risk ratio (RR) for each study. Where appropriate, we performed meta‐analysis using a Mantel‐Haenszel fixed‐effect model. </p> </section> <section id="CD000146-sec-0006"> <h3 class="title" id="CD000146-sec-0006">Main results</h3> <p>We identified 136 studies; 133 with 64,640 participants contributed to the primary comparison between any type of NRT and a placebo or non‐NRT control group. The majority of studies were conducted in adults and had similar numbers of men and women. People enrolled in the studies typically smoked at least 15 cigarettes a day at the start of the studies. We judged the evidence to be of high quality; we judged most studies to be at high or unclear risk of bias but restricting the analysis to only those studies at low risk of bias did not significantly alter the result. The RR of abstinence for any form of NRT relative to control was 1.55 (95% confidence interval (CI) 1.49 to 1.61). The pooled RRs for each type were 1.49 (95% CI 1.40 to 1.60, 56 trials, 22,581 participants) for nicotine gum; 1.64 (95% CI 1.53 to 1.75, 51 trials, 25,754 participants) for nicotine patch; 1.52 (95% CI 1.32 to 1.74, 8 trials, 4439 participants) for oral tablets/lozenges; 1.90 (95% CI 1.36 to 2.67, 4 trials, 976 participants) for nicotine inhalator; and 2.02 (95% CI 1.49 to 2.73, 4 trials, 887 participants) for nicotine nasal spray. The effects were largely independent of the definition of abstinence, the intensity of additional support provided or the setting in which the NRT was offered. Adverse events from using NRT were related to the type of product, and include skin irritation from patches and irritation to the inside of the mouth from gum and tablets. Attempts to quantitatively synthesize the incidence of various adverse effects were hindered by extensive variation in reporting the nature, timing and duration of symptoms. The odds ratio (OR) of chest pains or palpitations for any form of NRT relative to control was 1.88 (95% CI 1.37 to 2.57, 15 included and excluded trials, 11,074 participants). However, chest pains and palpitations were rare in both groups and serious adverse events were extremely rare. </p> </section> <section id="CD000146-sec-0007"> <h3 class="title" id="CD000146-sec-0007">Authors' conclusions</h3> <p>There is high‐quality evidence that all of the licensed forms of NRT (gum, transdermal patch, nasal spray, inhalator and sublingual tablets/lozenges) can help people who make a quit attempt to increase their chances of successfully stopping smoking. NRTs increase the rate of quitting by 50% to 60%, regardless of setting, and further research is very unlikely to change our confidence in the estimate of the effect. The relative effectiveness of NRT appears to be largely independent of the intensity of additional support provided to the individual. Provision of more intense levels of support, although beneficial in facilitating the likelihood of quitting, is not essential to the success of NRT. NRT often causes minor irritation of the site through which it is administered, and in rare cases can cause non‐ischaemic chest pain and palpitations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000146-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000146-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000146-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000146-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000146-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000146-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000146-abs-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000146-abs-0016">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD000146-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000146-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000146-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000146-abs-0012">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000146-abs-0005" lang="en"> <h3>Can nicotine replacement therapy (NRT) help people quit smoking?</h3> <p><b>Background</b> </p> <p>We reviewed the evidence about whether NRT helps people who want to quit smoking to stop smoking at six months or longer. NRT aims to reduce withdrawal symptoms associated with stopping smoking by replacing the nicotine from cigarettes. NRT is available as skin patches that deliver nicotine slowly, and chewing gum, nasal and oral sprays, inhalators, and lozenges/tablets, all of which deliver nicotine to the brain more quickly than skin patches, but less rapidly than from smoking cigarettes. </p> <p><b>Study characteristics</b> </p> <p>This review includes 136 trials of NRT, with 64,640 people in the main analysis. All studies were conducted in people who wanted to quit smoking. Most studies were conducted in adults and had similar numbers of men and women. People enrolled in the studies typically smoked at least 15 cigarettes a day at the start of the studies. The evidence is current to July 2017. Trials lasted for at least six months. </p> <p><b>Key results</b> </p> <p>We found evidence that all forms of NRT made it more likely that a person's attempt to quit smoking would succeed. The chances of stopping smoking were increased by 50% to 60%. NRT works with or without additional counselling, and does not need to be prescribed by a doctor. Side effects from using NRT are related to the type of product, and include skin irritation from patches and irritation to the inside of the mouth from gum and tablets. There is no evidence that NRT increases the risk of heart attacks. </p> <p><b>Quality of evidence</b> </p> <p>The overall quality of the evidence is high, meaning that further research is very unlikely to change our conclusions. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000146-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000146-sec-0072"></div> <h3 class="title" id="CD000146-sec-0073">Implications for practice</h3> <section id="CD000146-sec-0073"> <p> <ol id="CD000146-list-0002"> <li> <p>All of the commercially available forms of nicotine replacement therapy (NRT), i.e. gum, transdermal patch, nasal spray, inhalator, oral spray, lozenge and sublingual tablet, are effective as part of a strategy to promote smoking cessation. They increase the rate of long‐term quitting by approximately 50% to 60%, regardless of setting. These conclusions apply to smokers who are motivated to quit. There is little evidence about the role of NRT for individuals smoking fewer than 10 to 15 cigarettes a day. </p> </li> <li> <p>The form of delivery of NRT is unrelated to effectiveness, so other considerations such as preferences, availability, or cost might determine the form of NRT chosen. </p> </li> <li> <p>The effectiveness of NRT, in terms of the risk ratio, appears to be largely independent of the intensity of additional support provided. Intensive behavioural support is not essential for NRT to be effective. However, it should be noted that the absolute increase in success rates attributable to the use of NRT will be larger when the baseline chance of success is already raised by the provision of intensive behavioural support. </p> </li> <li> <p>NRT causes non‐ischaemic chest pain and palpitations in a minority of users but there is no evidence of an excess of serious cardiac problems, even in people with established cardiac disease. </p> </li> <li> <p>NRT commonly leads to minor adverse reactions which reflect irritation of the site of use of the form of NRT. These reactions are usually not severe enough to prompt discontinuation of treatment </p> </li> </ol> </p> </section> <h3 class="title" id="CD000146-sec-0074">Implications for research</h3> <section id="CD000146-sec-0074"> <p>There is high‐quality evidence that nicotine replacement therapy increases quit rates at six months or longer in adults motivated to quit. We consider that further research is highly unlikely to change our confidence in the effect of NRT in this population. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000146-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000146-sec-0029"></div> <div class="table" id="CD000146-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nicotine replacement therapy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Nicotine replacement therapy versus control for smoking cessation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who smoke cigarettes<br/> <b>Settings:</b> clinical and non‐clinical, including over the counter<br/> <b>Intervention:</b> nicotine replacement therapy of any form </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Nicotine replacement therapy of any form</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Smoking cessation at 6+ months follow‐up</b><br/> Follow‐up: 6 to 24 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.55</b> <br/> (1.49 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>64,640<br/> (133 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b><br/> (156 to 168) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Limited behavioural support</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b><br/> (60 to 64) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Intensive behavioural support</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>232 per 1000</b><br/> (224 to 242) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Most studies are judged to be at unclear or high risk of bias, but restricting to only studies at low risk of bias did not significantly alter the effect.<br/> <sup>2</sup>There are likely to be some unpublished trials with less favourable results that we were unable to identify, and a funnel plot showed some evidence of asymmetry. However, given the large number of trials in the review, this does not suggest the results would be altered significantly were smaller studies with lower RRs included. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000146-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000146-sec-0030"></div> <p>Nicotine replacement therapy (NRT) aims to reduce motivation to smoke and the physiological and psychomotor withdrawal symptoms often experienced during an attempt to stop smoking, and therefore increase the likelihood of remaining abstinent (<a href="./references#CD000146-bbs2-0320" title="WestR , .ShiffmanS . Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology Berl2001;155:115‐22. ">West 2001</a>). Nicotine undergoes first‐pass metabolism in the liver, reducing the overall bioavailability of swallowed nicotine pills. A pill that could reliably produce high enough nicotine levels in the central nervous system would risk causing adverse gastrointestinal effects. To avoid this problem, nicotine replacement products are formulated for absorption through the oral or nasal mucosa (chewing gum, lozenges, sublingual tablets, inhalator, spray) or through the skin (transdermal patches). </p> <p>Nicotine patches differ from the other products in that they deliver the nicotine dose slowly and passively. They do not replace any of the behavioural activities of smoking. In contrast the other types of NRT are faster‐acting, but require more effort on the part of the user. Transdermal patches are available in several different doses, and deliver between 5 mg and 52.5 mg of nicotine over a 24‐hour period, resulting in plasma levels similar to the trough levels seen in heavy smokers (<a href="./references#CD000146-bbs2-0278" title="FioreMC , JorenbyDE , BakerTB , KenfordSL . Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA1992;268:2687‐94. ">Fiore 1992</a>). Some brands of patch are designed to be worn for 24 hours whilst others are to be worn for 16 hours each day. Nicotine gum is available in both 2 mg and 4 mg strengths, and nicotine lozenges are available in 1 mg, 1.5 mg, 2 mg and 4 mg strengths. Nicotine nasal sprays are available in either 0.5 mg or 1 mg per spray strengths, and nicotine inhalators are available in both 10 mg and 15 mg strengths. The amount of nicotine absorbed by the user is less than the original dose. None of the available products deliver such high doses of nicotine as quickly as cigarettes. An average cigarette delivers between 1 and 3 mg of nicotine and a person who smokes 20 cigarettes per day absorbs 20 to 40 mg of nicotine each day (<a href="./references#CD000146-bbs2-0282" title="HenningfieldJE , FantRV , BuchhalterAR , StitzerML . Pharmacotherapy for nicotine dependence. CA Cancer Journal for Clinicians2005;55:281‐99. ">Henningfield 2005</a>). </p> <p>The availability of NRT products on prescription or for over‐the‐counter purchase varies from country to country. <a href="#CD000146-tbl-0002">Table 1</a> summarises the products currently licensed in the United Kingdom. </p> <div class="table" id="CD000146-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Nicotine replacement therapies available in the UK</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Available doses</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine transdermal patches</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Worn over 16 hours: 5 mg, 10 mg, 15 mg, 25 mg doses<br/> Worn over 24 hours: 7 mg, 14 mg, 20 mg, 21 mg, 30 mg doses* </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine chewing gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mg and 4 mg doses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine sublingual tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mg dose</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 mg, 1.5 mg, 2 mg and 4 mg doses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine inhalation cartridge plus mouthpiece</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cartridge containing 10 mg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine metered nasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg dose/spray</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine oral spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 mg dose/spray</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Information extracted from British National Formulary</p> <p>* 35 mg/24‐hour and 53.5 mg/24‐hour patches available in other regions.</p> </div> </div> <p>This review was first published over 20 years ago, in 1996, and has been regularly updated since. In previous versions, this review addressed not only the effect of NRT in comparison to placebo for helping people stop smoking, but also looked at comparisons between different forms and doses of NRT, and between NRT and different pharmacotherapies. The evidence that NRT helps some people to stop smoking is now well accepted, and many clinical guidelines recommend NRT as a first‐line treatment for people seeking pharmacological help to stop smoking (<a href="./references#CD000146-bbs2-0279" title="FioreMC , JaénCR , BakerTB , BaileyWC , BenowitzNL , CurrySJ , et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, May 2008. ">Fiore 2008</a>; <a href="./references#CD000146-bbs2-0287" title="OsservatorioFumo , Alcole Droga . Linee Guida Cliniche per Promuovere la Cessazione dell’Abitudine al Fumo. Rome: Istituto Superiore di Sanita, 2004. ">Italy ISS 2004</a>; <a href="./references#CD000146-bbs2-0293" title="LeFollB , Melihan‐CheininP , RostokerG , LagrueG . Smoking cessation guidelines: evidence‐based recommendations of the French Health Products Safety Agency. European Psychiatry2005;20:431‐41. ">Le Foll 2005</a>; <a href="./references#CD000146-bbs2-0303" title="National Institute for Health and Clinical Excellence. Public Health Guideline [PH10] Stop Smoking Services. National Institute for Health and Clinical Excellence, 2008. ">NICE 2008</a>; <a href="./references#CD000146-bbs2-0304" title="Ministry of Health. The New Zealand Guidelines for Helping People to Stop Smoking.. Wellington, New Zealand: Ministry of Health, 2014. ">NZ MoH 2014</a>; <a href="./references#CD000146-bbs2-0322" title="WoolacottNF , JonesL , ForbesCA , MatherLC , SowdenAJ , SongFJ , et al. The clinical effectiveness and cost‐effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment2002;6:1‐245. ">Woolacott 2002</a>; <a href="./references#CD000146-bbs2-0323" title="ZwarN , BorlandR , PetersM , LittJ , BellJ , CaldwellB , et al. Supporting Smoking Cessation: A Guide for Health Professionals. Melbourne: The Royal Australian College of General Practitioners, 2011. ">Zwar 2011</a>). We have therefore split the previous version of the review; this review now only looks at NRT versus placebo or no pharmacotherapy, with the intention that, given the stability of this comparison, this review will no longer require regular updates. Studies which compare doses, delivery, forms, and schedules of NRT will now be covered in a companion review, which will continue to be regularly updated, and is in development at the time of writing. Comparisons between NRT and other frontline pharmacotherapies are covered in separate Cochrane Reviews (<a href="./references#CD000146-bbs2-0264" title="CahillK , Lindson‐HawleyN , ThomasKH , FanshaweTR , LancasterT . Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD006103.pub7] ">Cahill 2016</a>; <a href="./references#CD000146-bbs2-0286" title="HughesJR , SteadLF , Hartmann‐BoyceJ , CahillK , LancasterT . Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4] ">Hughes 2014</a>). Where they meet our other inclusion criteria, studies of NRT in pregnancy are included in the main analysis of this review but are covered comprehensively in a separate Cochrane Review (<a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>), which will continue to be updated. Readers specifically interested in NRT in pregnancy should refer to <a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000146-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000146-sec-0031"></div> <p>To determine the effectiveness and safety of nicotine replacement therapy (NRT), including gum, transdermal patch, intranasal spray and inhaled and oral preparations, for achieving long‐term smoking cessation, compared to placebo or 'no NRT' interventions. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000146-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000146-sec-0032"></div> <section id="CD000146-sec-0033"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000146-sec-0034"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials. We also include trials where allocation to treatment was by a quasi‐randomized method, but use appropriate sensitivity analysis to determine whether their inclusion alters the results. </p> </section> <section id="CD000146-sec-0035"> <h4 class="title">Types of participants</h4> <p>We include men or women who smoked and were motivated to quit, irrespective of the setting from which they were recruited or their initial level of nicotine dependence, or both. We included studies that randomized therapists, rather than smokers, to offer NRT or a control, provided that the specific aim of the study was to examine the effect of NRT on smoking cessation. We have not included trials that randomized physicians or other therapists to receive an educational intervention, which included encouraging their patients to use NRT, but have reviewed them separately (<a href="./references#CD000146-bbs2-0265" title="CarsonKV , VerbiestMEA , CroneMR , BrinnMP , EstermanAJ , AssendelftWJJ , et al. Training health professionals in smoking cessation. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD000214.pub2] ">Carson 2012</a>). </p> </section> <section id="CD000146-sec-0036"> <h4 class="title">Types of interventions</h4> <p>Comparisons of NRT (including chewing gum, transdermal patches, nasal and oral spray, inhalators and tablets or lozenges) versus placebo or no NRT control. The terms 'inhaler' and 'inhalator' (an oral device which delivers nicotine to the buccal mucosa by sucking) are used interchangeably in the literature. We have used the term 'inhalator' throughout the rest of this review. </p> <p>In some analyses we categorized the trials into groups depending on the level of additional support provided (low or high). The definition of the low‐intensity category was intended to identify a level of support that could be offered as part of the provision of routine medical care. If the duration of time spent with the smoker (including assessment for the trial) exceeded 30 minutes at the initial consultation or the number of further assessment and reinforcement visits exceeded two, we categorized the level of additional support as high. The high‐intensity category included trials where there were a large number of visits to the clinic or trial centre, but these were often brief, spread over an extended period during treatment and follow‐up, and did not include a specific counselling component. To provide a more fine‐grained analysis and to distinguish between high‐intensity group‐based support and other trials within the high‐intensity category, we have therefore specified where the support included multi‐session group‐based counselling with frequent sessions around the quit date. </p> <p>Previously, this review had also included studies where all arms received NRT (e.g. testing different doses, types) and studies comparing NRT with bupropion. These comparisons are now covered elsewhere; comparisons between different NRT treatments are covered in a companion review, currently under development, and comparisons between NRT and bupropion are found in <a href="./references#CD000146-bbs2-0286" title="HughesJR , SteadLF , Hartmann‐BoyceJ , CahillK , LancasterT . Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4] ">Hughes 2014</a>. </p> </section> <section id="CD000146-sec-0037"> <h4 class="title">Types of outcome measures</h4> <p>The review evaluates the effects of NRT versus control on smoking cessation, rather than on withdrawal symptoms. We excluded trials that followed up participants for less than six months, except for trials amongst pregnant women, where the interval between enrolment and delivery may have been shorter (if less than six months, these were excluded from the main analysis). For each study we chose the strictest available criteria to define abstinence. For example, in studies where biochemical validation of cessation was available, we regard only those participants who met the criteria for biochemically‐confirmed abstinence as being abstinent. Wherever possible we chose a measure of sustained cessation rather than point prevalence. We regard people who were lost to follow‐up as being continuing smokers.<br/> <br/> For the 2012 update and for this current update we collected data on adverse events in both the included and excluded studies, where they were reported. We have not attempted to pool these findings, apart from one meta‐analysis of reports of palpitations, tachycardia or chest pains.<br/> We have not included trials that evaluated the effect of NRT for individuals who were attempting to reduce the number of cigarettes smoked rather than to quit in this review. They are covered by a separate review on harm reduction approaches (<a href="./references#CD000146-bbs2-0294" title="Lindson‐HawleyN , Hartmann‐BoyceJ , FanshaweTR , BeghR , FarleyA , LancasterT . Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews2016, Issue 10. [DOI: 10.1002/14651858.CD005231.pub3] ">Lindson‐Hawley 2016</a>). </p> </section> </section> <section id="CD000146-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched the specialized register of the Cochrane Tobacco Addiction Group on 6 July 2017 for any reports of trials making reference to the use of nicotine replacement therapy of any type, by searching for 'NRT', or 'nicotine' near to terms for nicotine replacement products in the title, abstract or keywords. The most recent issues of the databases included in the register as searched for the current update of this review were: </p> <p> <ul id="CD000146-list-0001"> <li> <p>Cochrane Central Register of Controlled trials (CENTRAL), issue 11, 2016;</p> </li> <li> <p>MEDLINE (via OVID) to update 20170526;</p> </li> <li> <p>Embase (via OVID) to week 201724;</p> </li> <li> <p>PsycINFO (via OVID) to update 20170529.</p> </li> </ul> </p> <p>The search strategy for the Register is given in <a href="./appendices#CD000146-sec-0078">Appendix 1</a>. For details of the searches used to create the specialized register see the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/TOBACCO/frame.html" target="_blank">Tobacco Addiction Group Module</a> in the Cochrane Library. The trials register also includes trials identified by handsearching of abstract books from meetings of the Society for Research on Nicotine and Tobacco. </p> <p>For earlier versions of this review we performed searches of additional databases: Cancerlit, Health Planning and Administration, Social Scisearch, Smoking &amp; Health, and Dissertation Abstracts. Since the searches did not produce any additional trials we did not search these databases after December 1996. During preparation of the first version of this review, we also sent letters to manufacturers of NRT preparations. Since this did not result in additional data we have not repeated the exercise for subsequent updates. </p> </section> <section id="CD000146-sec-0039"> <h3 class="title" id="CD000146-sec-0039">Data collection and analysis</h3> <section id="CD000146-sec-0040"> <h4 class="title">Selection of studies</h4> <p>In previous versions of this review, one review author screened records retrieved by searches, to exclude papers that were not reports of potentially relevant studies. For the last two updates, two review authors independently screened references. Reports that linked to potentially relevant studies but did not report the outcomes of interest are listed along with the main study report in the 'References to Studies' section. The primary reference to the study is indicated, and for most studies the first author and year used as the study identifier corresponds to the primary reference. Where we extracted data for a study from more than one report we have noted this in the <a href="./references#CD000146-sec-0104" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD000146-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data from the published reports and abstracts. We resolved disagreements by discussion or by referral to a third party. We made no attempt to blind these review authors either to the results of the primary studies or to which treatment participants received. We examined reports published only in non‐English language journals with the assistance of translators. </p> </section> <section id="CD000146-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed included studies for risks of selection bias (methods of randomized sequence generation, and allocation concealment), performance and detection bias (the presence or absence of blinding), attrition bias (levels and reporting of loss to follow‐up), and any other threats to study validity, using the Cochrane 'Risk of bias' tool. </p> </section> <section id="CD000146-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>We extracted smoking cessation rates in the intervention and control groups from the reports at six or 12 months. Since not all studies reported cessation rates at exactly these intervals, we allowed a window period of six weeks at each follow‐up point. For trials which also reported follow‐up for more than a year we used 12‐month outcomes in most cases. (We note length of follow‐up for each study in the <a href="./references#CD000146-sec-0104" title="">Characteristics of included studies</a> table). For trials of NRT in pregnant women, we extracted smoking cessation outcomes at the closest follow‐up to end of pregnancy, and also at longest follow‐up post‐partum if reported. We only included studies in pregnant women in the main analysis if they reported results at six months or longer. Following the Cochrane Tobacco Addiction Group's recommended method of data analysis, we use the risk ratio (RR) for summarizing individual trial outcomes and for estimates of pooled effect. Whilst there are circumstances in which odds ratios may be preferable, there is a danger that they will be interpreted as if they are risk ratios, making the treatment effect seem larger (<a href="./references#CD000146-bbs2-0272" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. in: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Deeks 2005</a>). </p> </section> <section id="CD000146-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>We treated participants who dropped out or who were lost to follow‐up after randomization as being continuing smokers. We noted in the 'Risk of bias' table the proportion of participants for whom the outcome was imputed in this way, and whether there was either high or differential loss to follow‐up. The assumption that 'missing = smoking' will give conservative absolute quit rates, and will make little difference to the risk ratio unless dropout rates differ substantially between groups. </p> </section> <section id="CD000146-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>To assess heterogeneity we use the I<sup>2</sup> statistic, given by the formula [(Q ‐ df)/Q] x 100%, where Q is the Chi<sup>2</sup> statistic and df is its degrees of freedom (<a href="./references#CD000146-bbs2-0283" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). This describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (chance). A value greater than 50% may be considered to indicate substantial heterogeneity. When there are many trials, as in this review, the Chi<sup>2</sup> test for heterogeneity will be unduly powerful and may identify statistically significant but clinically unimportant heterogeneity. </p> </section> <section id="CD000146-sec-0046"> <h4 class="title">Data synthesis</h4> <p>We estimated a pooled weighted average of risk ratios using a fixed‐effect Mantel‐Haenszel method, with 95% confidence intervals. </p> </section> <section id="CD000146-sec-0047"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In comparing NRT to placebo or control, we performed subgroup analysis for each form of NRT. We did additional subgroup analyses within type of NRT (gum, patch, etc.) to investigate whether the relative treatment effect differed according to the way in which smoking cessation was defined, the intensity of behavioural support, and the recruitment/treatment setting. </p> <section id="CD000146-sec-0048"> <h5 class="title">Summary of findings table</h5> <p>Following standard Cochrane methodology, we created a 'Summary of findings' table. Also following standard Cochrane methodology, we used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome, and to draw conclusions about the quality of evidence within the text of the review. </p> <p>The Cochrane Tobacco Addiction Group's Glossary of smoking‐related terms is included in this review (<a href="./appendices#CD000146-sec-0079">Appendix 2</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000146-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000146-sec-0049"></div> <section id="CD000146-sec-0050"> <h3 class="title">Description of studies</h3> <section id="CD000146-sec-0051"> <h4 class="title">Included studies</h4> <p>The review includes 136 studies, 18 of which are new in this update (<a href="./references#CD000146-bbs2-0004" title="AnthenelliR , BenowitzN , WestR , StAubinL , McRaeT , LawrenceD , et al. Reports of suicidal ideation and behavior in the EAGLES trial. Society for Research on Nicotine and Tobacco; 2016 March 03‐05; USA. 2016; Vol. SYM5D:8. AnthenelliRM , BenowitzNL , WestR , StAubinL , McRaeT , LawrenceD , et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double‐blind, randomised, placebo‐controlled clinical trial. Lancet2016; Vol. 387, issue 10037:2507‐20. [DOI: dx.doi.org/10.1016/S0140‐6736(16)30272‐0] BenowitzN , EvinsAE , WestR , StAubinL , McRaeT , LawrenceD , et al. EAGLES trial: study design and neuropsychiatric safety results. Society for Research on Nicotine and Tobacco; 2016 March 03‐05; USA. 2016; Vol. SYM5B:7. NCT01456936 . A phase 4, randomized, double blind, active and placebo controlled multicenter study evaluating the neuropsychiatric safety and efficacy of 12 weeks varenicline tartrate 1mg BID and bupropion hydrochloride 150 mg BID for smoking cessation in subjects with and without a history of psychiatric disorders [EAGLES]. clinicaltrials.gov/ct2/show/NCT01456936 (first received 21 October 2011). ProchaskaJ . Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use. Society for Research on Nicotine and Tobacco; 2016 March 03‐05; USA. 2016; Vol. SYM5A:7. ProchaskaJ , BenowitzN , WestR , AnthenelliR . Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled trial comparing the safety and efficacy of the first‐line smoking cessation aids in smokers with and without pychiatric disorders. Society for Research on Nicotine and Tobacco; 2016 March 03‐05; USA. 2016; Vol. SYM5:7. WestR , BenowitzN , EvinsAE , StAubinL , McRaeT , LawrenceD , et al. Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial. Society for Research on Nicotine and Tobacco; 2016 March 03‐05. 2016; Vol. SYM5C:8. ">Anthenelli 2016</a>; <a href="./references#CD000146-bbs2-0006" title="BerlinI , GrangeG , JacobN , TanguyML . Nicotine patches in pregnant smokers: Randomised, placebo controlled, multicentre trial of efficacy. BMJ (online)2014;348:1622. LancasterT . In pregnant smokers, the nicotine patch did not increase abstinence or birthweight more than placebo. Annals of Internal Medicine2014;160(12):JC11. ">Berlin 2014</a>; <a href="./references#CD000146-bbs2-0023" title="CumminsS , ZhuSH , GamstA , KirbyC , BrandsteinK , Klonoff‐CohenH , et al. Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial. Trials2012;13(1):128. CumminsSE , GamstAC , BrandsteinK , SeymannGB , Klonoff‐CohenH , KirbyCA , et al. Helping hospitalized smokers: a factorial RCT of nicotine patches and counseling. American Journal of Preventive Medicine2016;51(4):578‐86. ">Cummins 2016</a>; <a href="./references#CD000146-bbs2-0024" title="CunninghamJA , KushnirV , SelbyP , TyndaleRF , ZawertailoL , LeatherdaleST . Effect of mailing nicotine patches on tobacco cessation among adult smokers: a randomized clinical trial. JAMA Internal Medicine2016;176(2):184‐90. KushnirV , SprouleBA , CunninghamJA . Mailed distribution of free nicotine patches without behavioral support: Predictors of use and cessation. Addictive Behaviors2017;67:73‐8. KushnirV , SprouleBA , ZawertailoL , SelbyP , TyndaleRF , LeatherdaleST , et al. Impact of self‐reported lifetime depression or anxiety on effectiveness of mass distribution of nicotine patches. Tobacco Control2016;26(5):526‐33. WiseJ . Mailing free nicotine patches to smokers reduces smoking rates, study shows. BMJ (Clinical research ed.)2016;352:i468. ">Cunningham 2016</a>; <a href="./references#CD000146-bbs2-0030" title="El‐MohandesAA , WindsorR , TanS , PerryDC , GantzMG , KielyM . A randomized clinical trial of trans‐dermal nicotine replacement in pregnant African‐American smokers. Maternal and Child Health Journal2013;17(5):897‐906. ">El‐Mohandes 2013</a>; <a href="./references#CD000146-bbs2-0037" title="FraserD , KobinskyK , SmithSS , KramerJ , TheobaldWE , BakerTB . Five population‐based interventions for smoking cessation: a MOST trial. Translational Behavioral Medicine2014;4(4):382‐90. ">Fraser 2014</a>; <a href="./references#CD000146-bbs2-0038" title="GallagherSM , PennPE , SchindlerE . Smoking cessation in persons with schizophrenia and other serious mental illness (PA1‐5). Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006; Orlando, Florida, USA. 2006. GallagherSM , PennPE , SchindlerE , LayneW . A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs2007;39(4):487‐97. ">Gallagher 2007</a>; <a href="./references#CD000146-bbs2-0046" title="GrahamAL , ChaS , PapandonatosGD , CobbNK , MushroA , FangY , et al. Improving adherence to web‐based cessation programs: a randomized controlled trial study protocol. Trials2013;14:48. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS . Improving adherence to smoking cessation treatment: smoking outcomes in a web‐based randomized trial. Annals of Behavioral Medicine2018;52(4):331‐41. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS , CobbNK , et al. Improving adherence to smoking cessation treatment: Intervention effects in a web‐based randomized trial. Nicotine &amp; Tobacco Research2017;19(3):324‐32. ">Graham 2017</a>; <a href="./references#CD000146-bbs2-0053" title="HasanFM , ZagarinsSE , PischkeKM , SaiyedS , BettencourtAM , BealL , et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complementary Therapies in Medicine2014;22(1):1‐8. ">Hasan 2014</a>; <a href="./references#CD000146-bbs2-0056" title="HeydariG , TalischiF , TaftiSF , MasjediMR . Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran. International Journal of Tuberculosis and Lung Disease2012;16(2):268‐72. [CENTRAL: 814663; CRS: 9400123000012712; EMBASE: 2012026893; PUBMED: 22236931] ">Heydari 2012</a>; <a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>; <a href="./references#CD000146-bbs2-0072" title="JohnsD . Randomised controlled trial comparing nicotine replacement therapy (nrt) and counselling on smoking cessation in patients prone to lung cancer using bed font micro‐smokerlyzer. International MASCC/ISOO Symposium: Supportive Care in Cancer; 2017; USA. 2017:S102. ">Johns 2017</a>; <a href="./references#CD000146-bbs2-0081" title="LermanC , SchnollRA , HawkLWJr , CinciripiniP , GeorgeTP , WileytoEP , et al. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double‐blind placebo‐controlled trial. Lancet Respiratory Medicine2015;3(2):131‐8. RabinRA , AshareRL , SchnollRA , CinciripiniPM , HawkLWJr , LermanC , et al. Does cannabis use moderate smoking cessation outcomes in treatment‐seeking tobacco smokers? Analysis from a large multi‐center trial. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions2016;25(4):291‐6. ">Lerman 2015</a>; <a href="./references#CD000146-bbs2-0090" title="NCT00534404 . iQuit Smoking: a randomized trial of internet access to nicotine patches. clinicaltrials.gov/show/NCT00534404 (first received 24 September 2007). ">NCT00534404</a>; <a href="./references#CD000146-bbs2-0112" title="ScherphofCS , Van denEijndenRJ , EngelsRCME , VolleberghWA . Short‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. Journal of Substance Abuse Treatment2014;46(2):120‐7. ScherphofCS , Van denEijndenRJ , LugtigP , EngelsRCME , VolleberghWA . Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories. Psychopharmacology2014;231(8):1743‐52. ScherphofCS , Van denEijndenRJJM , EngelsRCME , VolleberghWAM . Long‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial. Drug and Alcohol Dependence2014;140:217‐20. ">Scherphof 2014</a>; <a href="./references#CD000146-bbs2-0124" title="DeDiosMA , AndersonBJ , CavinessCM , SteinMD . Early quit days among methadone‐maintained smokers in a smoking cessation trial. Nicotine &amp; Tobacco Research2014;16(11):1463‐9. [CENTRAL: 1042497; CRS: 9400129000003420] NCT00790569 . Varenicline versus nicotine replacement for methadone‐maintained smokers. ClinicalTrials.gov/ct2/ (first received 13 November 2008). [CRS: 9400123000011408] SteinMD , CavinessCM , KurthME , AudetD , OlsonJ , AndersonBJ . Varenicline for smoking cessation among methadone‐maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] ">Stein 2013</a>; <a href="./references#CD000146-bbs2-0128" title="TuiskuA , SalmelaM , NieminenP , ToljamoT . Varenicline and nicotine patch therapies in young adults motivated to quit smoking: a randomized, placebo‐controlled, prospective Studys. Basic &amp; Clinical Pharmacology &amp; Toxicology2016;119(1):78‐84. ">Tuisku 2016</a>; <a href="./references#CD000146-bbs2-0137" title="Ben TalebZ , WardKD , AsfarT , BahelahR , MaziakW . Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria. Drug and Alcohol Dependence2015;153:167‐72. Ben TalebZ , WardKD , AsfarT , JaberR , AufR , MaziakW . Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low‐income country setting. International Journal of Public Health2016;61(6):701‐8. Ben TalebZ , WardKD , AsfarT , JaberR , BahelahR , MaziakW . Smoking cessation and changes in body mass index: Findings from the first randomized cessation trial in a low‐income country setting. Nicotine &amp; Tobacco Research2017;19(3):351‐6. Ben TalebZ , WardKD , AsfarT , JaberR , BahelahR , MaziakW . Smoking cessation and changes in body mass index: findings from the first randomized cessation trial in a low‐Income country setting. Nicotine &amp; Tobacco Research2016;19(3):351‐56. LandoH . Commentary on Ward et al. (2013): failure to find a treatment effect for NRT in a low‐income country ‐ implications. Addiction (Abingdon, England)2013;108(2):404‐5. WardKD , AsfarT , Al AliR , RastamS , WegMW , EissenbergT , et al. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction (Abingdon, England)2013;108(2):394‐403. ">Ward 2013</a>). Two studies which gave different doses of NRT based on level of dependency are treated as four separate trials for the purpose of this review (<a href="./references#CD000146-bbs2-0119" title="DreslerCM , ShiffmanS , StrahsKR . Safety profile of the new nicotine polacrilex lozenge (PO1 36). Society for Research on Nicotine and Tobacco 8th Annual Meeting: 2002; Savannah, Georgia, USA. 2002. FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS . Nicotine lozenge efficacy in light smokers. Drug &amp; Alcohol Dependence2005;77:311‐4. ShiffmanS . Use of more nicotine lozenges leads to better success in quitting smoking. Addiction2007;102:809‐14. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ShiffmanS , DreslerCM , RohayJM . Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction2004;99:83‐92. ">Shiffman 2002 (2 mg)</a>; <a href="./references#CD000146-bbs2-0120" title="FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ">Shiffman 2002 (4 mg)</a>; <a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a>; <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>). For this update, we also added longer follow‐up data for one previously included study (<a href="./references#CD000146-bbs2-0021" title="BowkerKA , LewisS , ColemanT , VazLR , CooperS . Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(6):895‐8. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK Britton J , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. The New England Journal of Medicine2012;366(9):808‐19. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK , BrittonJ , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. Obstetrical &amp; Gynecological Survey2012;67(7):387‐8. ColemanT , ThorntonJ , BrittonJ , LewisS , WattsK , CoughtrieMWH , et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: Double‐blind, placebo‐randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research2007;7:2. CooperS , LewisS , ThorntonJG , MarlowN , WattsK , BrittonJ , et al. The SNAP trial: a randomised placebo‐controlled trial of nicotine replacement therapy in pregnancy‐‐clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment (Winchester, England)2014;18(54):1‐128. CooperS , TaggarJ , LewisS , MarlowN , DickinsonA , WhitemoreR , et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow‐up from the randomised, double‐blind, placebo‐controlled SNAP trial [Erratum appears in Lancet Respiratory Medicine. 2014 Nov;2(11):e22]. Lancet Respiratory Medicine2014;2(9):728‐37. EssexHN , ParrottS , WuQ , LiJ , CooperS , ColemanT . Cost‐effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomized controlled trial (SNAP). Nicotine &amp; Tobacco Research2015;17(6):636‐42. GraingeM , ColemanT , CooperS , ThorntonJ , WattsK , BrittonJ , et al. Double‐blind, placebo‐controlled, randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine2011;39:Suppl:172. ThorntonJG , ColemanT , BrittonJ , CooperS , WattsK , LewisS , et al. The smoking, nicotine and pregnancy (SNAP) trial: Main results. Archives of Disease in Childhood: Fetal and Neonatal Edition2011;96:Fa109. VazLR , AveyardP , CooperS , Leonardi‐BeeJ , ColemanT , WattsK , et al. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine &amp; Tobacco Research2016;18(10):1952‐9. VazLR , ColemanT , CooperS , AveyardP , Leonardi‐BeeJ , Snap trial team. The nicotine metabolite ratio in pregnancy measured by trans‐3'‐hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine &amp; Tobacco Research2015;17(11):1318‐23. VazLR , Leonardi‐BeeJ , AveyardP , CooperS , GraingeM , ColemanT . Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(4):381‐9. ">Coleman 2012</a>). The most recent search screened 1059 studies. Along with the 18 new included studies, there were three ongoing studies, and 124 studies excluded at full‐text screening. The most common reasons for exclusion were ineligible study design and using an irrelevant comparison (NRT vs NRT rather than control). See <a href="#CD000146-fig-0001">Figure 1</a> for study flow information relating to the most recent search presented in a PRISMA diagram. Trials were conducted in North America (62 studies), Europe (56 studies), Australasia (two studies), Japan (two studies), South America (two studies), Iran (two studies), in multiple regions (two studies), and in India, Syria, Taiwan, and Thailand (one study each). The median sample size was 257 but ranged from fewer than 50 to over 8000 participants. We treated each of the intervention groups in the two studies by Shiffman in 2002 and 2009 separately in the meta‐analysis (<a href="./references#CD000146-bbs2-0119" title="DreslerCM , ShiffmanS , StrahsKR . Safety profile of the new nicotine polacrilex lozenge (PO1 36). Society for Research on Nicotine and Tobacco 8th Annual Meeting: 2002; Savannah, Georgia, USA. 2002. FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS . Nicotine lozenge efficacy in light smokers. Drug &amp; Alcohol Dependence2005;77:311‐4. ShiffmanS . Use of more nicotine lozenges leads to better success in quitting smoking. Addiction2007;102:809‐14. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ShiffmanS , DreslerCM , RohayJM . Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction2004;99:83‐92. ">Shiffman 2002 (2 mg)</a>; <a href="./references#CD000146-bbs2-0120" title="FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ">Shiffman 2002 (4 mg)</a>; <a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a>; <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>), and listed <a href="./references#CD000146-bbs2-0010" title="BrantmarkB , OhlinP , WestlingH . Nicotine‐containing chewing gum as an anti‐smoking aid. Psychopharmacologia1973;31:191‐200. ">Brantmark 1973b</a>, <a href="./references#CD000146-bbs2-0017" title="TønnesenP , PaolettiP , GustavssonG , RussellMA , SaracciR , GulsvikA , et al. Higher dosage nicotine patches increase one‐year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal1999;13:238‐46. ">CEASE 1999</a>, <a href="./references#CD000146-bbs2-0009" title="BolligerCT . Practical experiences in smoking reduction and cessation. Addiction2000;95(1 S1):S19‐S24. BolligerCT , ZellwegerJP , DanielssonT , VanBiljonX , RobidouA , WestinA , et al. Influence of long‐term smoking reduction on health risk markers and quality of life. Nicotine &amp; Tobacco Research2002;4:433‐9. BolligerCT , ZellwegerJP , DanielssonT , VanBiljonX , RobidouA , WestinA , et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ2000;321(7257):329‐33. ">Bolliger 2000b</a>, <a href="./references#CD000146-bbs2-0138" title="WennikeP , DanielssonT , LandfeldtB , WestinA , TønnesenP . Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo‐controlled trial of nicotine gum with 2‐year follow‐up. Addiction2003;98(10):1395‐402. ">Wennike 2003b</a>, <a href="./references#CD000146-bbs2-0013" title="BullenC , HoweC , LinRB , GriggM , LaugesenM , McRobbieH , et al. Pre‐cessation nicotine replacement therapy: pragmatic randomized trial. Addiction2010;105(8):1474‐83. ">Bullen 2010</a>, <a href="./references#CD000146-bbs2-0117" title="LermanC , JepsonC , WileytoEP , PattersonF , SchnollR , MroziewiczM , et al. Genetic variation in nicotine metabolism predicts the efficacy of extended‐duration transdermal nicotine therapy. Clinical Pharmacology &amp; Therapeutics2010;87(5):553‐7. SchnollRA , PattersonF , WileytoEP , HeitjanDF , ShieldsAE , AschDA , et al. Effectiveness of extended‐duration transdermal nicotine therapy: a randomized trial. Annals of Internal Medicine2010;152(3):144‐51. SchnollRA , WileytoEP , LermanC . Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addictive Behaviors2012;37:565‐8. ">Schnoll 2010</a> in the <a href="./references#CD000146-sec-0104" title="">Characteristics of included studies</a> tables, despite being excluded studies, because they provided data on adverse events. </p> <div class="figure" id="CD000146-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for most recent update" data-id="CD000146-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for most recent update</p> </div> </div> </div> <section id="CD000146-sec-0052"> <h5 class="title">Participants</h5> <p>Participants were typically adult cigarette smokers with an average age of 40 to 50. Two trials recruited adolescents (<a href="./references#CD000146-bbs2-0087" title="CollinsCC , EpsteinDH , ParzynskiCS , ZimmermanD , MoolchanET , HeishmanSJ . Puffing behavior during the smoking of a single cigarette in tobacco‐dependent adolescents. Nicotine &amp; Tobacco Research2010;12:164‐7. FrankenFH , PickworthWB , EpsteinDH , MoolchanET . Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiology, Biomarkers &amp; Prevention2006;15:154‐7. Jaszyna‐GasiorM , SchroederJR , ThornerED , HeishmanSJ , CollinsCC , LoS , et al. Age at menarche and weight concerns in relation to smoking trajectory and dependence among adolescent girls enrolled in a smoking cessation trial. Addictive Behaviors2009;34(1):92‐5. MoolchanET , RobinsonML , ErnstM , CadetJL , PickworthWB , HeishmanSJ , et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics2005;115(4):e407‐e414. RobinsonML , SchroederJR , MoolchanET . Adolescent smokers screened for a nicotine replacement treatment trial: Correlates of eligibility and enrollment. Nicotine &amp; Tobacco Research2006;8:447‐54. Thorner‐BantugE , Jaszyna‐GasiorM , SchroederJR , CollinsCC , MoolchanET . Weight gain, related concerns, and treatment outcomes among adolescent smokers enrolled in cessation treatment. Journal of the National Medical Association2009;101(10):1009‐14. ">Moolchan 2005</a>; <a href="./references#CD000146-bbs2-0112" title="ScherphofCS , Van denEijndenRJ , EngelsRCME , VolleberghWA . Short‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. Journal of Substance Abuse Treatment2014;46(2):120‐7. ScherphofCS , Van denEijndenRJ , LugtigP , EngelsRCME , VolleberghWA . Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories. Psychopharmacology2014;231(8):1743‐52. ScherphofCS , Van denEijndenRJJM , EngelsRCME , VolleberghWAM . Long‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial. Drug and Alcohol Dependence2014;140:217‐20. ">Scherphof 2014</a>). Most trials had approximately similar numbers of men and women. Six trials recruited only pregnant women (<a href="./references#CD000146-bbs2-0006" title="BerlinI , GrangeG , JacobN , TanguyML . Nicotine patches in pregnant smokers: Randomised, placebo controlled, multicentre trial of efficacy. BMJ (online)2014;348:1622. LancasterT . In pregnant smokers, the nicotine patch did not increase abstinence or birthweight more than placebo. Annals of Internal Medicine2014;160(12):JC11. ">Berlin 2014</a>; <a href="./references#CD000146-bbs2-0021" title="BowkerKA , LewisS , ColemanT , VazLR , CooperS . Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(6):895‐8. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK Britton J , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. The New England Journal of Medicine2012;366(9):808‐19. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK , BrittonJ , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. Obstetrical &amp; Gynecological Survey2012;67(7):387‐8. ColemanT , ThorntonJ , BrittonJ , LewisS , WattsK , CoughtrieMWH , et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: Double‐blind, placebo‐randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research2007;7:2. CooperS , LewisS , ThorntonJG , MarlowN , WattsK , BrittonJ , et al. The SNAP trial: a randomised placebo‐controlled trial of nicotine replacement therapy in pregnancy‐‐clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment (Winchester, England)2014;18(54):1‐128. CooperS , TaggarJ , LewisS , MarlowN , DickinsonA , WhitemoreR , et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow‐up from the randomised, double‐blind, placebo‐controlled SNAP trial [Erratum appears in Lancet Respiratory Medicine. 2014 Nov;2(11):e22]. Lancet Respiratory Medicine2014;2(9):728‐37. EssexHN , ParrottS , WuQ , LiJ , CooperS , ColemanT . Cost‐effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomized controlled trial (SNAP). Nicotine &amp; Tobacco Research2015;17(6):636‐42. GraingeM , ColemanT , CooperS , ThorntonJ , WattsK , BrittonJ , et al. Double‐blind, placebo‐controlled, randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine2011;39:Suppl:172. ThorntonJG , ColemanT , BrittonJ , CooperS , WattsK , LewisS , et al. The smoking, nicotine and pregnancy (SNAP) trial: Main results. Archives of Disease in Childhood: Fetal and Neonatal Edition2011;96:Fa109. VazLR , AveyardP , CooperS , Leonardi‐BeeJ , ColemanT , WattsK , et al. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine &amp; Tobacco Research2016;18(10):1952‐9. VazLR , ColemanT , CooperS , AveyardP , Leonardi‐BeeJ , Snap trial team. The nicotine metabolite ratio in pregnancy measured by trans‐3'‐hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine &amp; Tobacco Research2015;17(11):1318‐23. VazLR , Leonardi‐BeeJ , AveyardP , CooperS , GraingeM , ColemanT . Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(4):381‐9. ">Coleman 2012</a>; <a href="./references#CD000146-bbs2-0030" title="El‐MohandesAA , WindsorR , TanS , PerryDC , GantzMG , KielyM . A randomized clinical trial of trans‐dermal nicotine replacement in pregnant African‐American smokers. Maternal and Child Health Journal2013;17(5):897‐906. ">El‐Mohandes 2013</a>; <a href="./references#CD000146-bbs2-0096" title="DornelasE , OnckenC , GreeneJ , SankeyHZ , KranzlerHR . Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions2013;22(1):54‐9. FishLJ , PetersonBL , Namenek BrouwerRJ , LynaP , OnckenCA , SwamyG , et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine &amp; Tobacco Research2009;11(5):514‐8. OnckenC , DornelasE , GreeneJ , SankeyH , GlasmannA , FeinnR , et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstetrics &amp; Gynecology2008;112(4):859‐67. SwamyGK , RoelandsJJ , PetersonBL , FishLJ , OnckenCA , PletschP , et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics &amp; Gynecology2009;201(4):354‐7. ">Oncken 2008</a>; <a href="./references#CD000146-bbs2-0104" title="PollakKI , OnckenC , LipkusIM , PetersonBL , SwamyGK , PletschPK , et al. Effectiveness of adding nicotine replacement therapy to cognitive behavioral therapy for smoking cessation in pregnant smokers: the Baby Steps trial (PA6‐3). Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21‐24; Austin, Texas, USA. 2007:25. PollakKI , OnckenCA , LipkusIM , LynaP , SwamyGK , PletschPK , et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. American Journal of Preventive Medicine2007;33:297‐305. ">Pollak 2007;</a><a href="./references#CD000146-bbs2-0140" title="WisborgK , HenriksenTB , JespersenLB , SecherNJ . Nicotine patches for pregnant smokers: A randomized controlled study. Obstetrics &amp; Gynecology2000;96(6):967‐71. ">Wisborg 2000</a>); a further four recruited only women (<a href="./references#CD000146-bbs2-0022" title="CooperTV , KlesgesRC , DebonMW , ZbikowskiSM , JohnsonKC , ClemensLH . A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addictive Behaviors2005;30:61‐75. CooperTV , MontgomeryGV , DebonMW , ZbikowskiSM , KlesgesRC , JohnsonKC . The effects of PPA and nicotine gum on cessation rates and post cessation weight gain in women [POS3‐46]. Society for Research on Nicotine and Tobacco 9th Annual Meeting; 2003; New Orleans, LA. 2003. ">Cooper 2005</a>; <a href="./references#CD000146-bbs2-0095" title="AllenAM , KleppingerA , LandoH , OnckenC . Effect of nicotine patch on energy intake and weight gain in postmenopausal women during smoking cessation. Eating Behaviors2013;14(4):420‐3. KleppingerA , LittMD , KennyAM , OnckenCA . Effects of smoking cessation on body composition in postmenopausal women. Journal of Women's Health2010;19:1651‐57. OnckenC , CooneyJ , FeinnR , LandoH , KranzlerHR . Transdermal nicotine for smoking cessation in postmenopausal women. Addictive Behaviors2007;32:296‐309. OnckenC , CooneyJ , LandoH , FeinnR , KranzlerH . Transdermal nicotine for smoking cessation in postmenopausal women (POS1‐045). Society for Research on Nicotine and Tobacco 11th Annual Meeting; 2005; Prague, Czech Republic. 2005. ">Oncken 2007</a>; <a href="./references#CD000146-bbs2-0103" title="PiriePL , McBrideCM , HellerstedtWL , JefferyRW , HatsukamiDK , AllenS , et al. Smoking cessation in women concerned about weight. American Journal of Public Health1992;82:1238‐43. ">Pirie 1992</a>; <a href="./references#CD000146-bbs2-0105" title="PrapavessisH , CameronL , BaldiJC , RobinsonS , BorrieK , HarperT , et al. The effects of exercise and nicotine replacement therapy on smoking rates in women. Addictive Behaviors2007;32:1416‐32. ">Prapavessis 2007</a>). Two trials recruited African‐American smokers (<a href="./references#CD000146-bbs2-0002" title="AhluwaliaJS , McNagnySE , ClarkWS . Smoking cessation among inner‐city African Americans using the nicotine transdermal patch. Journal of General Internal Medicine1998;13(1):1‐8. ">Ahluwalia 1998</a>; <a href="./references#CD000146-bbs2-0003" title="AhluwaliaJS , OkuyemiK , NollenN , ChoiWS , KaurH , PulversK , et al. The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Addiction2006;101(6):883‐91. BergCJ , ThomasJL , GuoH , AnLC , OkuyemiKS , CollinsTC , et al. Predictors of smoking reduction among Blacks. Nicotine &amp; Tobacco Research2010;12(4):423‐31. NollenNL , MayoMS , Sanderson CoxL , OkuyemiKS , ChoiWS , KaurH , et al. Predictors of quitting among African American light smokers enrolled in a randomized, placebo‐controlled trial. Journal of General Internal Medicine2006;21(6):590‐5. OkuyemiKS , CoxLS , NollenNL , SnowTM , KaurH , ChoiW , et al. Baseline characteristics and recruitment strategies in a randomized clinical trial of African‐American light smokers. American Journal of Health Promotion2007;21(3):183‐91. OkuyemiKS , FaseruB , Sanderson CoxL , BronarsCA , AhluwaliaJS . Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction2007;102(12):1979‐86. OkuyemiKS , PulversKM , CoxLS , ThomasJL , KaurH , MayoMS , et al. Nicotine dependence among African American light smokers: a comparison of three scales. Addictive Behaviors2007;32(10):1989‐2002. OkuyemiKS , ThomasJL , WarrenJ , GuoH , AhluwaliaJS . Relationship between smoking reduction and cessation among light smokers. Nicotine &amp; Tobacco Research2010;12(10):1005‐10. OkuyemiKS , ZhengH , GuoH , AhluwaliaJS . Predictors of adherence to nicotine gum and counseling among African‐American light smokers. Journal of General Internal Medicine2010;25(9):969‐76. ThomasJL , BronarsCA , StewartDW , OkuyemiKS , BefortCA , NazirN , et al. Psychometric properties of a brief Smoking Consequences Questionnaire for Adults (SCQ‐A) among African American light smokers. Substance Abuse2009;30(1):14‐25. WarrenJR , OkuyemiKS , GuoH , ThomasJL , AhluwaliaJS . Predicting home smoking restrictions among African American light smokers. American Journal of Health Behavior2010;34(1):110‐18. WarrenJR , ThomasJL , OkuyemiKS , LindgrenB , AhluwaliaJS . Development and validation of a multidimensional measure of stress among African American light smokers. Journal of the National Medical Association2010;102(10):890‐7. WhemboluaGL , DavisJT , ReitzelLR , GuoH , ThomasJL , GoldadeKR , et al. Subjective social status predicts smoking abstinence among light smokers. American Journal of Health Behavior2012;36(5):639‐46. ">Ahluwalia 2006</a>). </p> <p>Trials typically recruited people who smoked at least 15 cigarettes a day. Although some trials included lighter smokers as well, the average number smoked was over 20 a day in most studies. <a href="./references#CD000146-bbs2-0003" title="AhluwaliaJS , OkuyemiK , NollenN , ChoiWS , KaurH , PulversK , et al. The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Addiction2006;101(6):883‐91. BergCJ , ThomasJL , GuoH , AnLC , OkuyemiKS , CollinsTC , et al. Predictors of smoking reduction among Blacks. Nicotine &amp; Tobacco Research2010;12(4):423‐31. NollenNL , MayoMS , Sanderson CoxL , OkuyemiKS , ChoiWS , KaurH , et al. Predictors of quitting among African American light smokers enrolled in a randomized, placebo‐controlled trial. Journal of General Internal Medicine2006;21(6):590‐5. OkuyemiKS , CoxLS , NollenNL , SnowTM , KaurH , ChoiW , et al. Baseline characteristics and recruitment strategies in a randomized clinical trial of African‐American light smokers. American Journal of Health Promotion2007;21(3):183‐91. OkuyemiKS , FaseruB , Sanderson CoxL , BronarsCA , AhluwaliaJS . Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction2007;102(12):1979‐86. OkuyemiKS , PulversKM , CoxLS , ThomasJL , KaurH , MayoMS , et al. Nicotine dependence among African American light smokers: a comparison of three scales. Addictive Behaviors2007;32(10):1989‐2002. OkuyemiKS , ThomasJL , WarrenJ , GuoH , AhluwaliaJS . Relationship between smoking reduction and cessation among light smokers. Nicotine &amp; Tobacco Research2010;12(10):1005‐10. OkuyemiKS , ZhengH , GuoH , AhluwaliaJS . Predictors of adherence to nicotine gum and counseling among African‐American light smokers. Journal of General Internal Medicine2010;25(9):969‐76. ThomasJL , BronarsCA , StewartDW , OkuyemiKS , BefortCA , NazirN , et al. Psychometric properties of a brief Smoking Consequences Questionnaire for Adults (SCQ‐A) among African American light smokers. Substance Abuse2009;30(1):14‐25. WarrenJR , OkuyemiKS , GuoH , ThomasJL , AhluwaliaJS . Predicting home smoking restrictions among African American light smokers. American Journal of Health Behavior2010;34(1):110‐18. WarrenJR , ThomasJL , OkuyemiKS , LindgrenB , AhluwaliaJS . Development and validation of a multidimensional measure of stress among African American light smokers. Journal of the National Medical Association2010;102(10):890‐7. WhemboluaGL , DavisJT , ReitzelLR , GuoH , ThomasJL , GoldadeKR , et al. Subjective social status predicts smoking abstinence among light smokers. American Journal of Health Behavior2012;36(5):639‐46. ">Ahluwalia 2006</a> recruited only people who smoked 10 or fewer cigarettes a day and two trials recruited only people smoking 30 or more a day (<a href="./references#CD000146-bbs2-0063" title="HughesJR , GustSW , KeenanRM , FenwickJW . Effect of dose on nicotine's reinforcing, withdrawal‐suppression and self‐reported effects. Journal of Pharmacology and Experimental Therapeutics1990;252:1175‐83. ">Hughes 1990</a>; <a href="./references#CD000146-bbs2-0065" title="HughesJR , NovyP , HatsukamiDK , JensenJ , CallasPW . Efficacy of nicotine patch in smokers with a history of alcoholism. Alcoholism‐Clinical and Experimental Research2003;27:946‐54. ">Hughes 2003</a>). One trial recruited people with a history of alcohol dependence (<a href="./references#CD000146-bbs2-0065" title="HughesJR , NovyP , HatsukamiDK , JensenJ , CallasPW . Efficacy of nicotine patch in smokers with a history of alcoholism. Alcoholism‐Clinical and Experimental Research2003;27:946‐54. ">Hughes 2003</a>), one recruited methadone‐maintained smokers (<a href="./references#CD000146-bbs2-0124" title="DeDiosMA , AndersonBJ , CavinessCM , SteinMD . Early quit days among methadone‐maintained smokers in a smoking cessation trial. Nicotine &amp; Tobacco Research2014;16(11):1463‐9. [CENTRAL: 1042497; CRS: 9400129000003420] NCT00790569 . Varenicline versus nicotine replacement for methadone‐maintained smokers. ClinicalTrials.gov/ct2/ (first received 13 November 2008). [CRS: 9400123000011408] SteinMD , CavinessCM , KurthME , AudetD , OlsonJ , AndersonBJ . Varenicline for smoking cessation among methadone‐maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] ">Stein 2013</a>), and one recruited people with a history of drug abuse including opiates or narcotics (<a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>). <a href="./references#CD000146-bbs2-0074" title="JosephAM , AntonnucioDO . Lack of efficacy of transdermal nicotine in smoking cessation. New England Journal of Medicine1999;341:1157‐8. JosephAM , NormanSM , FerryLH , ProchazkaAV , WestmanEC , SteeleBG , et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine1996;335:1792‐8. ">Joseph 1996</a> recruited people with a history of cardiac disease, <a href="./references#CD000146-bbs2-0053" title="HasanFM , ZagarinsSE , PischkeKM , SaiyedS , BettencourtAM , BealL , et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complementary Therapies in Medicine2014;22(1):1‐8. ">Hasan 2014</a> recruited people admitted to hospital with a cardiac or pulmonary illness, <a href="./references#CD000146-bbs2-0038" title="GallagherSM , PennPE , SchindlerE . Smoking cessation in persons with schizophrenia and other serious mental illness (PA1‐5). Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006; Orlando, Florida, USA. 2006. GallagherSM , PennPE , SchindlerE , LayneW . A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs2007;39(4):487‐97. ">Gallagher 2007</a> recruited people diagnosed with psychotic‐spectrum or affective disorders resulting in long‐term mental illness and experiencing significant symptoms and functional impairment, and <a href="./references#CD000146-bbs2-0045" title="GourlaySG , ForbesA , MarrinerT , PethicaD , McNeilJJ . Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ1995;311(7001):363‐6. ">Gourlay 1995</a> recruited relapsed smokers. </p> </section> <section id="CD000146-sec-0053"> <h5 class="title">Type and dose of nicotine replacement therapy</h5> <p>One hundred and thirty‐three studies contribute to the primary analysis of the efficacy of one or more types of NRT compared to a placebo or other control group not receiving any type of NRT. In this group of studies there were 56 trials of nicotine gum, 51 of transdermal nicotine patch, eight of an oral nicotine tablet or lozenge, seven offering a choice of products, four of intranasal nicotine spray, four of nicotine inhalator, two providing patch and gum (<a href="./references#CD000146-bbs2-0053" title="HasanFM , ZagarinsSE , PischkeKM , SaiyedS , BettencourtAM , BealL , et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complementary Therapies in Medicine2014;22(1):1‐8. ">Hasan 2014</a>; <a href="./references#CD000146-bbs2-0124" title="DeDiosMA , AndersonBJ , CavinessCM , SteinMD . Early quit days among methadone‐maintained smokers in a smoking cessation trial. Nicotine &amp; Tobacco Research2014;16(11):1463‐9. [CENTRAL: 1042497; CRS: 9400129000003420] NCT00790569 . Varenicline versus nicotine replacement for methadone‐maintained smokers. ClinicalTrials.gov/ct2/ (first received 13 November 2008). [CRS: 9400123000011408] SteinMD , CavinessCM , KurthME , AudetD , OlsonJ , AndersonBJ . Varenicline for smoking cessation among methadone‐maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] ">Stein 2013</a>), one of oral spray (<a href="./references#CD000146-bbs2-0134" title="TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo‐controlled, double blind, multicenter study with 52‐week follow up. Poster Presented at SRNT, Feb 16‐19th, 2011, Toronto, Canada. TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double blind trial. European Respiratory Journal2012;40(3):548‐54. [DOI: 10.1183/09031936.00155811] ">Tønnesen 2012</a>), one providing patch and inhalator (<a href="./references#CD000146-bbs2-0051" title="HandS , EdwardsS , CampbellIA , CanningsR . Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax2002;57:715‐8. ">Hand 2002</a>), one providing patch and lozenge (<a href="./references#CD000146-bbs2-0102" title="AsthanaA , JohnsonHM , PiperME , FioreMC , BakerTB , SteinJH . Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. American Heart Journal2010;160(3):458‐63. BergKM , PiperME , SmithSS , FioreMC , JorenbyDE . Defining and predicting short‐term alcohol use changes during a smoking cessation attempt. Addictive Behaviors2015;48:52‐7. GepnerAD , PiperME , JohnsonHM , FioreMC , BakerTB , SteinJH . Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. American Heart Journal2011;161(1):145‐51. JapuntichSJ , PiperME , LeventhalAM , BoltDM , BakerTB . The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Journal of Consulting &amp; Clinical Psychology2011;79(1):34‐42. JohnsonHM , GossettLK , PiperME , AeschlimannSE , KorcarzCE , BakerTB , et al. Effects of smoking and smoking cessation on endothelial function: 1‐year outcomes from a randomized clinical trial. Journal of the American College of Cardiology2010;55(18):1988‐95. PiperME , CookJW , SchlamTR , JorenbyDE , BakerTB . Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction2011;106(2):418‐27. PiperME , SmithSS , SchlamTR , FioreMC , JorenbyDE , FraserD , et al. A randomized placebo‐controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry2009;66(11):1253‐62. ">Piper 2009</a>), and one providing patch, gum and lozenge (<a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>). </p> <p>Three studies did not contribute to the primary analysis; two were conducted in pregnant women and did not follow up participants at six months or longer (<a href="./references#CD000146-bbs2-0006" title="BerlinI , GrangeG , JacobN , TanguyML . Nicotine patches in pregnant smokers: Randomised, placebo controlled, multicentre trial of efficacy. BMJ (online)2014;348:1622. LancasterT . In pregnant smokers, the nicotine patch did not increase abstinence or birthweight more than placebo. Annals of Internal Medicine2014;160(12):JC11. ">Berlin 2014</a>; <a href="./references#CD000146-bbs2-0030" title="El‐MohandesAA , WindsorR , TanS , PerryDC , GantzMG , KielyM . A randomized clinical trial of trans‐dermal nicotine replacement in pregnant African‐American smokers. Maternal and Child Health Journal2013;17(5):897‐906. ">El‐Mohandes 2013</a>), and one was conducted in recently relapsed smokers and is hence reported narratively in the text (<a href="./references#CD000146-bbs2-0045" title="GourlaySG , ForbesA , MarrinerT , PethicaD , McNeilJJ . Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ1995;311(7001):363‐6. ">Gourlay 1995</a>). </p> <p>Most trials comparing nicotine gum to control provided the 2 mg dose. A few provided 4 mg gum to more highly addicted smokers, and two used only the 4 mg dose (<a href="./references#CD000146-bbs2-0007" title="BlondalT . Controlled trial of nicotine polacrilex gum with supportive measures. Archives of Internal Medicine1989;149:1818‐21. ">Blondal 1989</a>; <a href="./references#CD000146-bbs2-0106" title="PuskaP , BjorkqvistS , KoskelaK . Nicotine‐containing chewing gum in smoking cessation: a double blind trial with half year follow‐up. Addictive Behaviors1979;4:141‐6. ">Puska 1979</a>). In three trials the physician offered nicotine gum but participants did not necessarily accept or use it (<a href="./references#CD000146-bbs2-0094" title="OckeneJK , KristellerJ , GoldbergR , AmickTL , PekowPS , HosmerD , et al. Increasing the efficacy of physician‐delivered smoking interventions: a randomized clinical trial. Journal of General Internal Medicine1991;6:1‐8. OckeneJK , KristellerJ , PbertL , HebertJR , LuippoldR , GoldbergRJ , et al. The physician‐delivered smoking intervention project: can short‐term interventions produce long‐term effects for a general outpatient population?. Health Psychology1994;13:278‐81. ">Ockene 1991</a>; <a href="./references#CD000146-bbs2-0099" title="PageAR , WaltersDJ , SchlegelRP , BestJA . Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription. Addictive Behaviors1986;11:443‐6. ">Page 1986</a>; <a href="./references#CD000146-bbs2-0110" title="RussellMA , MerrimanR , StapletonJ , TaylorW . Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. British Medical Journal (Clinical Research Ed.)1983;287:1782‐5. ">Russell 1983</a>). In one trial participants self‐selected 2 mg or 4 mg doses; we treat the two groups as separate trials in the meta‐analysis (<a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a>; <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>). The treatment period was typically two to three months, but ranged from three weeks to 12 months. Some trials did not specify how long the gum was available. Many of the trials included a variable period of dose tapering, but most encouraged participants to be gum‐free by six to 12 months. </p> <p>In nicotine patch trials the usual maximum daily dose was 15 mg for a 16‐hour patch, or 21 mg for a 24‐hour patch. Thirty‐two studies used a 24‐hour formulation and nine a 16‐hour product; the rest did not specify. One study offered, among other dosage options, a 52.5 mg/24‐hour patch (<a href="./references#CD000146-bbs2-0141" title="WittchenHU , HochE , KlotscheJ , MuehligS . Smoking cessation in primary care ‐ a randomized controlled trial of bupropion, nicotine replacements, CBT and a minimal intervention. International Journal of Methods in Psychiatric Research2011;20(1):28‐39. ">Wittchen 2011</a>). If studies tested more than one dose we combined all active arms in the comparison to placebo. For one study we included an arm with a lower maximum dose of 14 mg but excluded a 7 mg‐dose arm (<a href="./references#CD000146-bbs2-0127" title="DaughtonDM , FortmannSP , GloverED , HatsukamiDK , HeatleySA , LichtensteinE , et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post‐quit day. Preventive Medicine1999;28:113‐8. FergusonSG , GitchellJG , ShiffmanS , SembowerMA . Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10‐week, randomized, double‐blind, placebo‐controlled clinical trials of 21‐mg nicotine patch in adult smokers. Clinical Therapeutics2009;31(9):1957‐65. SwanGE , JackLM , WardMM . Subgroups of smokers with different success rates after use of transdermal nicotine. Addiction1997;92:207‐17. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six‐month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA1991;266:3133‐8. ">TNSG 1991</a>). The minimum duration of therapy ranged from three weeks (<a href="./references#CD000146-bbs2-0042" title="GlavasD , RumboldtM , RumboldtZ . Smoking cessation with nicotine replacement therapy among health care workers: randomized double‐blind study. Croatian Medical Journal2003;44:219‐24. ">Glavas 2003a</a>, half the participants of <a href="./references#CD000146-bbs2-0043" title="GlavasD , RumboldtZ . Smoking cessation using the transdermal nicotine system [Odvikavanje od pusenja transdermalnim nikotinskim sustavom]. Lijecnicki Vjesnik2003;125(1‐2):8‐12. ">Glavas 2003b</a>), to three months. </p> <p>There are eight studies of nicotine sublingual tablets or lozenges. Three used 2 mg sublingual tablets (<a href="./references#CD000146-bbs2-0044" title="GloverE , GloverP , FranzonM , SullivanR , CerulloC . Safety and efficacy of a nicotine sublingual tablet for smoking cessation [abstract]. Smoke Free 21st Century: 2nd European Conference on Tobacco or Health; 1999; Las Palmas de Gran Canaria. 1999. GloverED , FranzonM , SullivanCR , CerulloCL . A nicotine sublingual tablet for treating tobacco dependence [Abstract]. Society for Research on Nicotine and Tobacco 3rd Europe Conference; 2001 September; Paris, France. 2001:48. GloverED , GloverPN , FranzonM , SullivanCR , CerulloCC , HowellRM , et al. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine &amp; Tobacco Research2002;4:441‐50. GloverED , GloverPN , FranzonM , SullivanR , SullivanP , HowellR , et al. A nicotine sublingual tablet for smoking cessation: 6‐month data [Abstract]. 10th World Conference on Tobacco or Health; 1997 August 24‐28; Beijing, China. 1997. ">Glover 2002</a>; <a href="./references#CD000146-bbs2-0133" title="PbertL . Nurse‐conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support. Chest2006;130:314‐6. TonnesenP , MikkelsenK , BremannL . Nurse‐conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest2006;130:334‐42. ">Tønnesen 2006</a>; <a href="./references#CD000146-bbs2-0136" title="Pharmacia , Upjohn . Nicorette Nicotine Microtab Monograph. Chester: Adis International, 1998:Adis International, 1998. WallstromM , NilssonF , HirschJM . A double‐blind placebo controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation [abstract]. European Respiratory Journal1997; Vol. 10, issue Suppl 25:440S. WallstromM , NilssonF , HirschJM . A randomized double‐blind placebo‐controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction2000;95(8):1161‐71. ">Wallstrom 2000</a>). One used a 1 mg nicotine lozenge (<a href="./references#CD000146-bbs2-0027" title="DautzenbergB , PeifferG , ToulouseF , YvinecMJ , JacobN , KienzlerJL . Randomized trial assessment of nicotinell lozenge 1mg, a new oral nicotine replacement therapy. Society for Research on Nicotine and Tobacco 3rd European Conference; 2001; Paris, France. 2001:55. DautzenbergB , RuffF , VaucherM , MaillonP , JacobN , KienzlerJL , et al. First demonstration of the good efficacy/safety ratio of Nicotinell® 1mg Lozenge (NL 1mg), a new form of nicotine substitution, by randomised clinical trial. European Respiratory Journal2001;18 Suppl 33:12s. ">Dautzenberg 2001</a>). One used 2 mg or 4 mg lozenges according to dependence level based on manufacturers' instructions (<a href="./references#CD000146-bbs2-0102" title="AsthanaA , JohnsonHM , PiperME , FioreMC , BakerTB , SteinJH . Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. American Heart Journal2010;160(3):458‐63. BergKM , PiperME , SmithSS , FioreMC , JorenbyDE . Defining and predicting short‐term alcohol use changes during a smoking cessation attempt. Addictive Behaviors2015;48:52‐7. GepnerAD , PiperME , JohnsonHM , FioreMC , BakerTB , SteinJH . Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. American Heart Journal2011;161(1):145‐51. JapuntichSJ , PiperME , LeventhalAM , BoltDM , BakerTB . The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Journal of Consulting &amp; Clinical Psychology2011;79(1):34‐42. JohnsonHM , GossettLK , PiperME , AeschlimannSE , KorcarzCE , BakerTB , et al. Effects of smoking and smoking cessation on endothelial function: 1‐year outcomes from a randomized clinical trial. Journal of the American College of Cardiology2010;55(18):1988‐95. PiperME , CookJW , SchlamTR , JorenbyDE , BakerTB . Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction2011;106(2):418‐27. PiperME , SmithSS , SchlamTR , FioreMC , JorenbyDE , FraserD , et al. A randomized placebo‐controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry2009;66(11):1253‐62. ">Piper 2009</a>), and one used 2 mg or 4 mg based on participants' time to first cigarette of the day (TTFC); smokers whose TTFC was more than 30 minutes were randomized to 2 mg lozenges or placebo (<a href="./references#CD000146-bbs2-0119" title="DreslerCM , ShiffmanS , StrahsKR . Safety profile of the new nicotine polacrilex lozenge (PO1 36). Society for Research on Nicotine and Tobacco 8th Annual Meeting: 2002; Savannah, Georgia, USA. 2002. FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS . Nicotine lozenge efficacy in light smokers. Drug &amp; Alcohol Dependence2005;77:311‐4. ShiffmanS . Use of more nicotine lozenges leads to better success in quitting smoking. Addiction2007;102:809‐14. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ShiffmanS , DreslerCM , RohayJM . Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction2004;99:83‐92. ">Shiffman 2002 (2 mg)</a>), whilst smokers with a TTFC less than 30 minutes had higher‐dose 4 mg lozenges or placebo (<a href="./references#CD000146-bbs2-0120" title="FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction (Abingdon, England)2012;107(7):1349‐53. ShiffmanS , DreslerCM , HajekP , GilburtSJ , TargettDA , StrahsKR . Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine2002;162:1267‐76. ">Shiffman 2002 (4 mg)</a>). The two groups are treated in the meta‐analysis as separate trials. One trial did not report the lozenge dose (<a href="./references#CD000146-bbs2-0037" title="FraserD , KobinskyK , SmithSS , KramerJ , TheobaldWE , BakerTB . Five population‐based interventions for smoking cessation: a MOST trial. Translational Behavioral Medicine2014;4(4):382‐90. ">Fraser 2014</a>). There are four trials of intranasal nicotine spray (<a href="./references#CD000146-bbs2-0008" title="BlondalT , FranzonM , WestinA . A double‐blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal1997;10:1585‐90. BlondalT , OlafsdottirI , GunnarsdottirR , FranzonM , WestinA . Controlled trial of nicotine nasal spray as an aid to stopping smoking [abstract]. European Respiratory Journal1993;6(Suppl 17):631S. ">Blondal 1997</a>; <a href="./references#CD000146-bbs2-0059" title="HjalmarsonAI , FranzonM , WestinA , WiklundO . Effect of nicotine nasal spray on smoking cessation. A randomized, placebo‐controlled, double‐blind study. Archives of Internal Medicine1994;154:2567‐72. ">Hjalmarson 1994</a>; <a href="./references#CD000146-bbs2-0115" title="SchneiderNG , OlmsteadR , ModyFV , DoanK , FranzonM , JarvikME , et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo‐controlled, double‐blind trial. Addiction1995;90:1671‐82. ">Schneider 1995</a>; <a href="./references#CD000146-bbs2-0125" title="StapletonJA , SutherlandG , RussellMAH . How much does relapse after one year erode effectiveness of smoking cessation treatments? Long term follow up of randomised trial of nicotine nasal spray. BMJ1998;316(7134):830‐1. SutherlandG , StapletonJA , RussellMAH , JarvisMJ , HajekP , BelcherM , et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet1992;340:324‐9. ">Sutherland 1992</a>), one trial of oral nicotine spray (<a href="./references#CD000146-bbs2-0134" title="TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo‐controlled, double blind, multicenter study with 52‐week follow up. Poster Presented at SRNT, Feb 16‐19th, 2011, Toronto, Canada. TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double blind trial. European Respiratory Journal2012;40(3):548‐54. [DOI: 10.1183/09031936.00155811] ">Tønnesen 2012</a>), and four trials of nicotine inhalator (<a href="./references#CD000146-bbs2-0060" title="HjalmarsonA , NilssonF , SjöströmL , WiklundO . The nicotine inhaler in smoking cessation. Archives of Internal Medicine1997;157(15):1721‐8. ">Hjalmarson 1997</a>; <a href="./references#CD000146-bbs2-0080" title="LeischowSJ , NilssonF , FranzonM , HillA , OtteP , MerikleEP . Efficacy of the nicotine inhaler as an adjunct to smoking cessation. American Journal of Health Behavior1996;20:364‐71. ">Leischow 1996a</a>; <a href="./references#CD000146-bbs2-0116" title="SchneiderNG , OlmsteadR , NilssonF , ModyFV , FranzonM , DoanK . Efficacy of a nicotine inhaler in smoking cessation: a double‐blind, placebo controlled trial. Addiction1996;91:1293‐306. SchneiderNG , OlmsteadR , NilssonF , ModyFV , FranzonM , DoanK . Efficacy of a nicotine inhaler in smoking cessation: a double‐blind, placebo‐controlled trial [abstract]. Addiction1997;92:630. ">Schneider 1996</a>; <a href="./references#CD000146-bbs2-0131" title="TønnesenP , NorregaardJ , MikkelsenK , JorgensenS , NilssonF . A double‐blind trial of a nicotine inhaler for smoking cessation. JAMA1993;269:1268‐71. ">Tønnesen 1993</a>). </p> <p>As described above, seven studies tested combinations of patch and a short‐acting form of NRT (<a href="./references#CD000146-bbs2-0051" title="HandS , EdwardsS , CampbellIA , CanningsR . Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax2002;57:715‐8. ">Hand 2002</a>; <a href="./references#CD000146-bbs2-0053" title="HasanFM , ZagarinsSE , PischkeKM , SaiyedS , BettencourtAM , BealL , et al. Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: results of a randomized controlled trial. Complementary Therapies in Medicine2014;22(1):1‐8. ">Hasan 2014</a>; <a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>; <a href="./references#CD000146-bbs2-0078" title="KornitzerM , BoutsenM , DramaixM , ThijsJ , GustavssonG . Combined use of nicotine patch and gum in smoking cessation: a placebo‐controlled clinical trial. Preventive Medicine1995;24:41‐7. KornitzerM , BoutsenM , ThijsJ , GustavssonG . Efficiency and safety of combined use of nicotine patches and nicotine gum in smoking cessation: a placebo controlled double‐blind trial [abstract]. European Respiratory Journal1993;6(Suppl 17):630S. ">Kornitzer 1995</a>; <a href="./references#CD000146-bbs2-0087" title="CollinsCC , EpsteinDH , ParzynskiCS , ZimmermanD , MoolchanET , HeishmanSJ . Puffing behavior during the smoking of a single cigarette in tobacco‐dependent adolescents. Nicotine &amp; Tobacco Research2010;12:164‐7. FrankenFH , PickworthWB , EpsteinDH , MoolchanET . Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiology, Biomarkers &amp; Prevention2006;15:154‐7. Jaszyna‐GasiorM , SchroederJR , ThornerED , HeishmanSJ , CollinsCC , LoS , et al. Age at menarche and weight concerns in relation to smoking trajectory and dependence among adolescent girls enrolled in a smoking cessation trial. Addictive Behaviors2009;34(1):92‐5. MoolchanET , RobinsonML , ErnstM , CadetJL , PickworthWB , HeishmanSJ , et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics2005;115(4):e407‐e414. RobinsonML , SchroederJR , MoolchanET . Adolescent smokers screened for a nicotine replacement treatment trial: Correlates of eligibility and enrollment. Nicotine &amp; Tobacco Research2006;8:447‐54. Thorner‐BantugE , Jaszyna‐GasiorM , SchroederJR , CollinsCC , MoolchanET . Weight gain, related concerns, and treatment outcomes among adolescent smokers enrolled in cessation treatment. Journal of the National Medical Association2009;101(10):1009‐14. ">Moolchan 2005</a>; <a href="./references#CD000146-bbs2-0124" title="DeDiosMA , AndersonBJ , CavinessCM , SteinMD . Early quit days among methadone‐maintained smokers in a smoking cessation trial. Nicotine &amp; Tobacco Research2014;16(11):1463‐9. [CENTRAL: 1042497; CRS: 9400129000003420] NCT00790569 . Varenicline versus nicotine replacement for methadone‐maintained smokers. ClinicalTrials.gov/ct2/ (first received 13 November 2008). [CRS: 9400123000011408] SteinMD , CavinessCM , KurthME , AudetD , OlsonJ , AndersonBJ . Varenicline for smoking cessation among methadone‐maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] ">Stein 2013</a>; <a href="./references#CD000146-bbs2-0132" title="TønnesenP , MikkelsenKL . Smoking cessation with four nicotine replacement regimes in a lung clinic. European Respiratory Journal2000;16:717‐22. ">Tønnesen 2000</a>). Six studies offered participants a choice of products (<a href="./references#CD000146-bbs2-0046" title="GrahamAL , ChaS , PapandonatosGD , CobbNK , MushroA , FangY , et al. Improving adherence to web‐based cessation programs: a randomized controlled trial study protocol. Trials2013;14:48. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS . Improving adherence to smoking cessation treatment: smoking outcomes in a web‐based randomized trial. Annals of Behavioral Medicine2018;52(4):331‐41. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS , CobbNK , et al. Improving adherence to smoking cessation treatment: Intervention effects in a web‐based randomized trial. Nicotine &amp; Tobacco Research2017;19(3):324‐32. ">Graham 2017</a>; <a href="./references#CD000146-bbs2-0072" title="JohnsD . Randomised controlled trial comparing nicotine replacement therapy (nrt) and counselling on smoking cessation in patients prone to lung cancer using bed font micro‐smokerlyzer. International MASCC/ISOO Symposium: Supportive Care in Cancer; 2017; USA. 2017:S102. ">Johns 2017</a>; <a href="./references#CD000146-bbs2-0079" title="KralikovaE , KozakJ , RasmussenT , CortN . The clinical benefits of NRT‐supported smoking reduction. Nicotine &amp; Tobacco Research2002;4:243. KralikovaE , KozakJT , RasmussenT , GustavssonG , LeHouezecJ . Smoking cessation or reduction with nicotine replacement therapy: a placebo‐controlled double blind trial with nicotine gum and inhaler. BMC Public Health2009;9:433. ">Kralikova 2009</a>; <a href="./references#CD000146-bbs2-0086" title="MolyneuxA , LewisS , LeiversU , AndertonA , AntoniakM , BrackenridgeA , et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax2003;58(6):484‐8. ">Molyneux 2003</a>; <a href="./references#CD000146-bbs2-0097" title="OrtegaF , VelliscoA , MárquezE , López‐CamposJL , RodríguezA , De losÁngeles SánchezM , et al. Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients. Archivos de Bronconeumologia2011;47(1):3‐9. ValenciaB , OrtegaF , VelliscoA , Márquez‐MartínE , CamposJLL , RodríguezAM , et al. Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients [Abstract]. European Respiratory Journal2011;38(55):775s [P4224]. ">Ortega 2011</a>; <a href="./references#CD000146-bbs2-0104" title="PollakKI , OnckenC , LipkusIM , PetersonBL , SwamyGK , PletschPK , et al. Effectiveness of adding nicotine replacement therapy to cognitive behavioral therapy for smoking cessation in pregnant smokers: the Baby Steps trial (PA6‐3). Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21‐24; Austin, Texas, USA. 2007:25. PollakKI , OnckenCA , LipkusIM , LynaP , SwamyGK , PletschPK , et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. American Journal of Preventive Medicine2007;33:297‐305. ">Pollak 2007</a>). </p> </section> <section id="CD000146-sec-0054"> <h5 class="title">Treatment setting (studies in main comparison)</h5> <p>Twenty‐one trials in the main comparison recruited participants from primary care practices. A further two gum trials were undertaken in workplace clinics (<a href="./references#CD000146-bbs2-0032" title="FagerströmKO . Effects of nicotine chewing gum and follow‐up appointments in physician‐based smoking cessation. Preventive Medicine1984;13:517‐27. ">Fagerström 1984</a>; <a href="./references#CD000146-bbs2-0109" title="RotoP , OjalaA , SundmanK , JokinenK , PeltomaklR . Nicotine gum and withdrawal from smoking. Suomen Laakarllehtl1987;36:3445‐8. ">Roto 1987</a>), and one in a university clinic (<a href="./references#CD000146-bbs2-0052" title="HarackiewiczJM , BlairLW , SansoneC , EpsteinJA , StuchellRN . Nicotine gum and self‐help manuals in smoking cessation: an evaluation in a medical context. Addictive Behaviors1988;13:319‐30. ">Harackiewicz 1988</a>). One trial recruited through community physicians (<a href="./references#CD000146-bbs2-0092" title="NiauraR , GoldsteinMG , AbramsDB . Matching high and low‐dependence smokers to self‐help treatment with or without nicotine replacement. Preventive Medicine1994;23:70‐7. ">Niaura 1994</a>). Since participants in these trials were recruited in a similar way to primary care, we have aggregated them in the subgroup analysis by setting. We also included one patch trial conducted in Veterans Affairs Medical Centers and recruiting people with cardiac diseases in the primary care category (<a href="./references#CD000146-bbs2-0074" title="JosephAM , AntonnucioDO . Lack of efficacy of transdermal nicotine in smoking cessation. New England Journal of Medicine1999;341:1157‐8. JosephAM , NormanSM , FerryLH , ProchazkaAV , WestmanEC , SteeleBG , et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine1996;335:1792‐8. ">Joseph 1996</a>). We kept four trials recruiting pregnant women in antenatal clinics in a separate category (<a href="./references#CD000146-bbs2-0021" title="BowkerKA , LewisS , ColemanT , VazLR , CooperS . Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(6):895‐8. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK Britton J , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. The New England Journal of Medicine2012;366(9):808‐19. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK , BrittonJ , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. Obstetrical &amp; Gynecological Survey2012;67(7):387‐8. ColemanT , ThorntonJ , BrittonJ , LewisS , WattsK , CoughtrieMWH , et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: Double‐blind, placebo‐randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research2007;7:2. CooperS , LewisS , ThorntonJG , MarlowN , WattsK , BrittonJ , et al. The SNAP trial: a randomised placebo‐controlled trial of nicotine replacement therapy in pregnancy‐‐clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment (Winchester, England)2014;18(54):1‐128. CooperS , TaggarJ , LewisS , MarlowN , DickinsonA , WhitemoreR , et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow‐up from the randomised, double‐blind, placebo‐controlled SNAP trial [Erratum appears in Lancet Respiratory Medicine. 2014 Nov;2(11):e22]. Lancet Respiratory Medicine2014;2(9):728‐37. EssexHN , ParrottS , WuQ , LiJ , CooperS , ColemanT . Cost‐effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomized controlled trial (SNAP). Nicotine &amp; Tobacco Research2015;17(6):636‐42. GraingeM , ColemanT , CooperS , ThorntonJ , WattsK , BrittonJ , et al. Double‐blind, placebo‐controlled, randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine2011;39:Suppl:172. ThorntonJG , ColemanT , BrittonJ , CooperS , WattsK , LewisS , et al. The smoking, nicotine and pregnancy (SNAP) trial: Main results. Archives of Disease in Childhood: Fetal and Neonatal Edition2011;96:Fa109. VazLR , AveyardP , CooperS , Leonardi‐BeeJ , ColemanT , WattsK , et al. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine &amp; Tobacco Research2016;18(10):1952‐9. VazLR , ColemanT , CooperS , AveyardP , Leonardi‐BeeJ , Snap trial team. The nicotine metabolite ratio in pregnancy measured by trans‐3'‐hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine &amp; Tobacco Research2015;17(11):1318‐23. VazLR , Leonardi‐BeeJ , AveyardP , CooperS , GraingeM , ColemanT . Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(4):381‐9. ">Coleman 2012</a>; <a href="./references#CD000146-bbs2-0096" title="DornelasE , OnckenC , GreeneJ , SankeyHZ , KranzlerHR . Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions2013;22(1):54‐9. FishLJ , PetersonBL , Namenek BrouwerRJ , LynaP , OnckenCA , SwamyG , et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine &amp; Tobacco Research2009;11(5):514‐8. OnckenC , DornelasE , GreeneJ , SankeyH , GlasmannA , FeinnR , et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstetrics &amp; Gynecology2008;112(4):859‐67. SwamyGK , RoelandsJJ , PetersonBL , FishLJ , OnckenCA , PletschP , et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics &amp; Gynecology2009;201(4):354‐7. ">Oncken 2008</a>; <a href="./references#CD000146-bbs2-0102" title="AsthanaA , JohnsonHM , PiperME , FioreMC , BakerTB , SteinJH . Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. American Heart Journal2010;160(3):458‐63. BergKM , PiperME , SmithSS , FioreMC , JorenbyDE . Defining and predicting short‐term alcohol use changes during a smoking cessation attempt. Addictive Behaviors2015;48:52‐7. GepnerAD , PiperME , JohnsonHM , FioreMC , BakerTB , SteinJH . Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. American Heart Journal2011;161(1):145‐51. JapuntichSJ , PiperME , LeventhalAM , BoltDM , BakerTB . The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Journal of Consulting &amp; Clinical Psychology2011;79(1):34‐42. JohnsonHM , GossettLK , PiperME , AeschlimannSE , KorcarzCE , BakerTB , et al. Effects of smoking and smoking cessation on endothelial function: 1‐year outcomes from a randomized clinical trial. Journal of the American College of Cardiology2010;55(18):1988‐95. PiperME , CookJW , SchlamTR , JorenbyDE , BakerTB . Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction2011;106(2):418‐27. PiperME , SmithSS , SchlamTR , FioreMC , JorenbyDE , FraserD , et al. A randomized placebo‐controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry2009;66(11):1253‐62. ">Piper 2009</a>; <a href="./references#CD000146-bbs2-0140" title="WisborgK , HenriksenTB , JespersenLB , SecherNJ . Nicotine patches for pregnant smokers: A randomized controlled study. Obstetrics &amp; Gynecology2000;96(6):967‐71. ">Wisborg 2000</a>). Six of the gum trials, two of the nasal spray trials, an inhalator trial, an oral spray trial, and a patch trial were carried out in specialized smoking cessation clinics to which participants had usually been referred. Thirteen trials (five patch, three gum, three giving a combination of products and two giving a choice of products) were undertaken with hospital in‐ or outpatients, some of whom were recruited because they had a co‐existing smoking‐related illness. Three patch trials (<a href="./references#CD000146-bbs2-0028" title="DavidsonM , EpsteinM , BurtR , SchaeferC , WhitworthG , McDonaldA . Efficacy and safety of an over‐the‐counter transdermal nicotine patch as an aid for smoking cessation. Archives of Family Medicine1998;7:569‐74. ">Davidson 1998</a>; <a href="./references#CD000146-bbs2-0054" title="HaysJT , CroghanGA , OffordKP , HurtRD , SchroederDR , WolterTD , et al. Over‐the‐counter nicotine patch therapy for smoking cessation: Results from randomized, double‐blind, placebo‐controlled and open label trials. American Journal of Public Health1999;89:1701‐7. HaysJT , CroghanGA , OffordKP , WolterTD , NidesMA , DavidsonM . Over‐the‐Counter (OTC) transdermal nicotine patch therapy [abstract]. Journal of Addictive Diseases1997;16:136. HaysJT , CroghanIT , OffordKP , HurtRD , SchroederDR , WolterTD , et al. Over the counter 22mg nicotine patch therapy for smoking cessation: results from randomized double‐blind placebo‐controlled and open label trials. Society for Research on Nicotine and Tobacco 5th Annual Meeting; 1999; San Diego, CA, USA1999. ">Hays 1999</a>; <a href="./references#CD000146-bbs2-0126" title="SønderskovJ , OlsenJ , MeillierL , OvervadOK , SabroeS . The effect of transdermal nicotine patches in smoking cessation. A randomized trial in pharmacy customers in Denmark. Ugeskrift for Laeger1999;161:593‐7. SønderskovJ , OlsenJ , SabroeS , MeillierL , OvervadK . Nicotine patches in smoking cessation: A randomized trial among over‐ the‐counter customers in Denmark. American Journal of Epidemiology1997;145:309‐18. ">Sønderskov 1997</a>) and one gum trial (split into <a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a> and <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>) were undertaken in settings intended to resemble 'over‐the‐counter' (OTC) use of NRT. Two trials were undertaken in drug abuse treatment centres (<a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>; <a href="./references#CD000146-bbs2-0124" title="DeDiosMA , AndersonBJ , CavinessCM , SteinMD . Early quit days among methadone‐maintained smokers in a smoking cessation trial. Nicotine &amp; Tobacco Research2014;16(11):1463‐9. [CENTRAL: 1042497; CRS: 9400129000003420] NCT00790569 . Varenicline versus nicotine replacement for methadone‐maintained smokers. ClinicalTrials.gov/ct2/ (first received 13 November 2008). [CRS: 9400123000011408] SteinMD , CavinessCM , KurthME , AudetD , OlsonJ , AndersonBJ . Varenicline for smoking cessation among methadone‐maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] ">Stein 2013</a>), one in schools (<a href="./references#CD000146-bbs2-0112" title="ScherphofCS , Van denEijndenRJ , EngelsRCME , VolleberghWA . Short‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. Journal of Substance Abuse Treatment2014;46(2):120‐7. ScherphofCS , Van denEijndenRJ , LugtigP , EngelsRCME , VolleberghWA . Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories. Psychopharmacology2014;231(8):1743‐52. ScherphofCS , Van denEijndenRJJM , EngelsRCME , VolleberghWAM . Long‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial. Drug and Alcohol Dependence2014;140:217‐20. ">Scherphof 2014</a>), and one in a psychiatric treatment setting. The remaining trials were undertaken in participants from the community, most of whom had volunteered in response to media advertisements, but who were treated in clinical settings. </p> </section> </section> <section id="CD000146-sec-0055"> <h4 class="title">Excluded studies</h4> <p>Thirty‐four previously included studies were removed from this update, as they did not contain a NRT‐versus‐control comparison. As described in the Methods, studies which contribute to comparisons between multiple forms of NRT are now found in a separate Cochrane Review, in development at the time of publication. Previously‐included studies that compare NRT with bupropion can be found in <a href="./references#CD000146-bbs2-0286" title="HughesJR , SteadLF , Hartmann‐BoyceJ , CahillK , LancasterT . Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4] ">Hughes 2014</a>. Other studies that were potentially relevant but excluded are listed with reasons in the <a href="./references#CD000146-sec-0105" title="">Characteristics of excluded studies</a> table. Some studies contribute to the adverse events meta‐analysis but not to the main analysis (e.g. due to short follow‐up or short duration of time where comparison was NRT versus control); these are listed in the <a href="./references#CD000146-sec-0104" title="">Characteristics of included studies</a> but we do not count them as included studies. Some studies were excluded due to short follow‐up. Some of these had as their primary outcome withdrawal symptoms rather than cessation. We exclude studies that provided NRT or placebo to people trying to cut down their smoking but not to make an immediate quit attempt, and we consider them in detail in a separate review of interventions for reduction (<a href="./references#CD000146-bbs2-0294" title="Lindson‐HawleyN , Hartmann‐BoyceJ , FanshaweTR , BeghR , FarleyA , LancasterT . Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews2016, Issue 10. [DOI: 10.1002/14651858.CD005231.pub3] ">Lindson‐Hawley 2016</a>). We excluded two trials in which NRT was provided to encourage a quit attempt but participants did not need to be planning to quit: <a href="./references#CD000146-bbs2-0249" title="VelicerWF , FriedmanRH , FavaJL , GulliverSB , KellerS , SunX , et al. Evaluating nicotine replacement therapy and stage‐based therapies in a population‐based effectiveness trial. Journal of Consulting &amp; Clinical Psychology2006;74:1162‐72. VelicerWF , KellerS , FriedmanRH , FavaJL , GulliverSB , WardRM , et al. Comparing participants and nonparticipants recruited for an effectiveness study of nicotine replacement therapy. Annals of Behavioral Medicine2005;29:181‐91. ">Velicer 2006</a> proactively recruited people by telephone, with those in one intervention group being mailed a six‐week course of nicotine patches if they were judged to be in the preparation stage or in contemplation and had more pros than cons for quitting; <a href="./references#CD000146-bbs2-0155" title="CarpenterMJ , AlbergAJ , GrayKM , SaladinME . Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clinical Trials2010;7(2):157‐66. CarpenterMJ , HughesJR , GrayKM , WahlquistAE , SaladinME , AlbergAJ . Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Archives of Internal Medicine2011;171(21):1901‐7. ">Carpenter 2011</a> encouraged all participants to make a practice quit attempt, and gave the intervention group trial samples of nicotine lozenges. We excluded one trial in which callers to the NHS Quitline were randomized to be offered free NRT or not to receive the offer; the control group had access to and used free NRT and other stop‐smoking medication at high levels (<a href="./references#CD000146-bbs2-0174" title="ColemanT , McEwenA , BauldL , FergusonJ , LorgellyP , LewisS . Protocol for the Proactive Or Reactive Telephone Smoking CeSsation Support (PORTSSS) trial. Trials2009;10(26). FergusonJ , DochertyG , BauldL , LewisS , LorgellyP , BoydKA , et al. Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJMarch 2012;344:e1696. [DOI: 10.1136/bmj.e1696] ">Ferguson 2012</a>). </p> </section> </section> <section id="CD000146-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <p>Six trials are included based only on data available from abstracts, conference presentations, or trial registries (<a href="./references#CD000146-bbs2-0027" title="DautzenbergB , PeifferG , ToulouseF , YvinecMJ , JacobN , KienzlerJL . Randomized trial assessment of nicotinell lozenge 1mg, a new oral nicotine replacement therapy. Society for Research on Nicotine and Tobacco 3rd European Conference; 2001; Paris, France. 2001:55. DautzenbergB , RuffF , VaucherM , MaillonP , JacobN , KienzlerJL , et al. First demonstration of the good efficacy/safety ratio of Nicotinell® 1mg Lozenge (NL 1mg), a new form of nicotine substitution, by randomised clinical trial. European Respiratory Journal2001;18 Suppl 33:12s. ">Dautzenberg 2001</a>; <a href="./references#CD000146-bbs2-0072" title="JohnsD . Randomised controlled trial comparing nicotine replacement therapy (nrt) and counselling on smoking cessation in patients prone to lung cancer using bed font micro‐smokerlyzer. International MASCC/ISOO Symposium: Supportive Care in Cancer; 2017; USA. 2017:S102. ">Johns 2017</a>; <a href="./references#CD000146-bbs2-0079" title="KralikovaE , KozakJ , RasmussenT , CortN . The clinical benefits of NRT‐supported smoking reduction. Nicotine &amp; Tobacco Research2002;4:243. KralikovaE , KozakJT , RasmussenT , GustavssonG , LeHouezecJ . Smoking cessation or reduction with nicotine replacement therapy: a placebo‐controlled double blind trial with nicotine gum and inhaler. BMC Public Health2009;9:433. ">Kralikova 2009</a>; <a href="./references#CD000146-bbs2-0088" title="MoriT , ShimaoT , YulchiroG , NamikiM , HyachiT . A clinical trial of nicotine chewing gum for smoking cessation [abstract 428]. 8th World Conference on Tobacco or Health; 1992; Buenos Aires, Argentina. 1992. ">Mori 1992</a>; <a href="./references#CD000146-bbs2-0089" title="NakamuraM , SaitoJ , OshimaA , MiyamotoM , MatushitaA , EndoS . Effect of nicotine chewing gun in smoking cessation classes. The Global War. Proceedings of the 7th World Conference on Tobacco and Health; 1990; Perth, Western Australia. Perth: Health Department of Western Australia, 1990:665‐7. ">Nakamura 1990</a>; <a href="./references#CD000146-bbs2-0090" title="NCT00534404 . iQuit Smoking: a randomized trial of internet access to nicotine patches. clinicaltrials.gov/show/NCT00534404 (first received 24 September 2007). ">NCT00534404</a>), so had limited methodological details. </p> <p>Overall, we judged 12 studies to be at low risk of bias (low risk of bias across all domains), 36 at high risk of bias (high risk of bias in at least one domain), and the rest at unclear risk of bias. The main findings were not sensitive to the exclusion from the meta‐analysis of trials at unclear risk, or of trials at unclear and at high risk of bias. A summary illustration of the risk of bias profile across trials is shown in <a href="#CD000146-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD000146-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000146-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>Thirty‐nine studies (29%) reported allocation procedures in sufficient detail to be rated as being at low risk for their attempts to control selection bias, by using a system of treatment allocation which could not be known or predicted until a participant is enrolled and assigned to a study condition. Twenty‐four of these low‐risk trials (62%) also reported adequate sequence generation procedures. Most studies either did not report how randomization was performed and allocation concealed, or reported them in insufficient detail to determine whether a satisfactory attempt to control selection bias had been made (rated as being at unclear risk). A small number of nicotine gum trials randomized to treatment according to day or week of clinic attendance (<a href="./references#CD000146-bbs2-0099" title="PageAR , WaltersDJ , SchlegelRP , BestJA . Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription. Addictive Behaviors1986;11:443‐6. ">Page 1986</a>; <a href="./references#CD000146-bbs2-0107" title="RichmondR , HeatherN . General Practitioner interventions for smoking cessation: past results and future prospects. Behaviour Change1990;7:110‐9. RichmondRL , MakinsonRJ , GiugniAA , WebsterIW . General Practitioner smoking interventions in Australia: results of studies over the past ten years. The Global War: Proceedings of the 7th World Conference on Tobacco and Health; 1990; Perth, Western Australia. Perth: Health Department of Western Australia, 1990:657‐60. RichmondRL , MakinsonRJ , KehoeLA , GiugniAA , WebsterIW . One‐year evaluation of three smoking cessation interventions administered by general practitioners. Addictive Behaviors1993;18:187‐99. ">Richmond 1993</a>; <a href="./references#CD000146-bbs2-0110" title="RussellMA , MerrimanR , StapletonJ , TaylorW . Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. British Medical Journal (Clinical Research Ed.)1983;287:1782‐5. ">Russell 1983</a>), or to birth date (<a href="./references#CD000146-bbs2-0032" title="FagerströmKO . Effects of nicotine chewing gum and follow‐up appointments in physician‐based smoking cessation. Preventive Medicine1984;13:517‐27. ">Fagerström 1984</a>), and were consequently rated as being at high risk of bias. In one study (<a href="./references#CD000146-bbs2-0038" title="GallagherSM , PennPE , SchindlerE . Smoking cessation in persons with schizophrenia and other serious mental illness (PA1‐5). Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006; Orlando, Florida, USA. 2006. GallagherSM , PennPE , SchindlerE , LayneW . A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs2007;39(4):487‐97. ">Gallagher 2007</a>), study staff oversaw allocation and hence we rated this at high risk of bias. One study randomized by physician and there was no information about avoidance of selection bias in enrolment of smokers (<a href="./references#CD000146-bbs2-0091" title="NebotM , CabezasC . Does nurse counseling or offer of nicotine gum improve the effectiveness of physician smoking‐cessation advice?. Family Practice Research Journal1992;12:263‐70. ">Nebot 1992</a>), so we also rated this as being at high risk. </p> <p>We judged 44 of the included studies to be at low risk of performance and detection bias (33%). We judged 23 (17%) to be at high risk of bias in this domain, most commonly because they were not blinded (although we judged some studies which were not double‐blind to be at low risk in this domain due to other study factors). Forty‐three trials did not have a matched placebo control (24 gum trials, nine patch trials, six choice of product trials, three combination trials, and one lozenge trial). A further two had both a placebo and a non‐placebo control which we combined for the meta‐analysis control group (<a href="./references#CD000146-bbs2-0012" title="BuchkremerG , BentsH , HorstmannM , OpitzK , TolleR . Combination of behavioral smoking cessation with transdermal nicotine substitution. Addictive Behaviors1989;14:229‐38. BuchkremerG , BentsH , MinnekerE , OpitzK . Long‐term effects of a combination of transdermal nicotine administration with behavior therapy for smoking cessation [Langfristige Effekte einer Kombination von transdermaler Nikotinzufuhr mit Verhaltenstherapie zur Raucherentwohnung]. Nervenarzt1988;59:488‐90. ">Buchkremer 1988</a>; <a href="./references#CD000146-bbs2-0110" title="RussellMA , MerrimanR , StapletonJ , TaylorW . Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. British Medical Journal (Clinical Research Ed.)1983;287:1782‐5. ">Russell 1983</a>). Approximately one‐third of the trials reported some measure of blinding, but we did not assess whether the integrity of the procedure was tested, in line with the CONSORT guidelines (<a href="./references#CD000146-bbs2-0269" title="AltmanDG , SchulzKF , MoherD , EggerM , DavidoffF , ElbourneD , et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine2001;134:663‐94. ">CONSORT 2001</a>). Where they are done, assessments of blinding integrity should always be carried out before the clinical outcome has been determined, and the findings reported (<a href="./references#CD000146-bbs2-0261" title="AltmanDG , SchulzKF , MoherD . Turning a blind eye: testing the success of blinding and the CONSORT statement. BMJ2004;328(7448):1135. ">Altman 2004</a>). <a href="./references#CD000146-bbs2-0299" title="MooneyM , WhiteT , HatsukamiD . The blind spot in the nicotine replacement therapy literature: assessment of the double‐blind in clinical trials. Addictive Behaviors2004;29(4):673‐84. ">Mooney 2004</a> notes that few published trials report this information. While those that do provide some evidence that participants are likely to assess their treatment assignment correctly, it is insufficient to assess whether this is associated with differences in treatment effects. Further, there may be an apparent breaking of the blinding in trials where the treatment effect is marked, for either an intended outcome or an adverse event, but participants who successfully decipher assignment may disguise their unblinding actions (<a href="./references#CD000146-bbs2-0261" title="AltmanDG , SchulzKF , MoherD . Turning a blind eye: testing the success of blinding and the CONSORT statement. BMJ2004;328(7448):1135. ">Altman 2004</a>). It is also possible that those who believe that they are receiving a placebo may be more likely to stop trying to quit. </p> <p>Definitions of abstinence varied considerably. Eighty‐nine trials (66%) reported some measure of sustained abstinence, which included continuous abstinence with not even a slip since quit day, repeated point prevalence abstinence (with or without biochemical validation) at multiple follow‐ups, or self‐reported abstinence for a prolonged period. Thirty‐nine (29%) reported only point prevalence abstinence at the longest follow‐up. In six studies it was unclear exactly how abstinence was defined. In four trials, participants who smoked two or three cigarettes a week were still classified as abstinent (<a href="./references#CD000146-bbs2-0001" title="AbelinT , BuehlerA , MullerP , VesanenK , ImhofPR . Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet1989;1(8628):7‐10. AbelinT , EhrsamR , Buhler‐ReichertA , ImhofPR , MullerP , ThommenA . Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods and Findings in Experimental and Clinical Pharmacology1989;11(3):205‐14. MullerP , AbelinT , EhrsamR , ImhofP , HowaldH , MauliD . The use of transdermal nicotine in smoking cessation. Lung1990;168 Suppl:445‐53. ">Abelin 1989</a>; <a href="./references#CD000146-bbs2-0029" title="AbelinT , EhrsamR , Buhler‐ReichertA , ImhofPR , MullerP , ThommenA , et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods and Findings in Experimental and Clinical Pharmacology1989;11:205‐14. AbelinT , EhrsamR , ImhofP , MullerP , HowaldH . Clinical experience with a transdermal nicotine system in healthy nicotine‐dependent smokers. In: WilhemsenL editor(s). Smoking as a Cardiovascular Risk Factor ‐ New Strategies for Smoking Cessation. Hogrefe &amp; Huber, 1991:35‐46. EhrsamRE , BuhlerA , MullerP , MauliD , SchumacherPM , HowaldH , et al. Weaning of young smokers using a transdermal nicotine patch [Entwohnung junger Raucher mit Hilfe eines transdermalen Nikotinpflasters]. Schweizerische Rundschau fur Medizin Praxis1991;80:145‐50. MullerP , AbelinT , EhrsamR , ImhofP , HowaldH , MauliD . The use of transdermal nicotine in smoking cessation. Lung1990;168:445‐53. ">Ehrsam 1991</a>; <a href="./references#CD000146-bbs2-0042" title="GlavasD , RumboldtM , RumboldtZ . Smoking cessation with nicotine replacement therapy among health care workers: randomized double‐blind study. Croatian Medical Journal2003;44:219‐24. ">Glavas 2003a</a>; <a href="./references#CD000146-bbs2-0043" title="GlavasD , RumboldtZ . Smoking cessation using the transdermal nicotine system [Odvikavanje od pusenja transdermalnim nikotinskim sustavom]. Lijecnicki Vjesnik2003;125(1‐2):8‐12. ">Glavas 2003b</a>). Sensitivity analyses excluding these four trials made no difference to the overall findings. Most studies reported follow‐up at least 12 months from start of treatment. Fifteen gum trials, 19 patch trials, four combination trials, and one lozenge trial in the primary analysis had only six months follow‐up. We report the findings of a subgroup analysis by type of abstinence and length of follow‐up in the Results section. </p> <p>One hundred and seventeen (87%) of the trials used biochemical validation of self‐reported smoking cessation at longest follow‐up. The most common form of validation was measurement of carbon monoxide (CO) in expired air. The 'cut‐off' level of CO used to define abstinence varied from less than 4 to 11 parts per million. Some of the 21 trials that did not validate all self‐report at longest follow‐up did use biochemical confirmation at earlier points, or validated some self‐reports. The main findings were not sensitive to the exclusion of 17 studies contributing to that analysis that did not attempt to validate all reported abstinence (<a href="./references#CD000146-bbs2-0002" title="AhluwaliaJS , McNagnySE , ClarkWS . Smoking cessation among inner‐city African Americans using the nicotine transdermal patch. Journal of General Internal Medicine1998;13(1):1‐8. ">Ahluwalia 1998</a>; <a href="./references#CD000146-bbs2-0012" title="BuchkremerG , BentsH , HorstmannM , OpitzK , TolleR . Combination of behavioral smoking cessation with transdermal nicotine substitution. Addictive Behaviors1989;14:229‐38. BuchkremerG , BentsH , MinnekerE , OpitzK . Long‐term effects of a combination of transdermal nicotine administration with behavior therapy for smoking cessation [Langfristige Effekte einer Kombination von transdermaler Nikotinzufuhr mit Verhaltenstherapie zur Raucherentwohnung]. Nervenarzt1988;59:488‐90. ">Buchkremer 1988</a>; <a href="./references#CD000146-bbs2-0020" title="Clavel‐ChapelonF , PaolettiC , BenhamouS . A randomised 2 x 2 factorial design to evaluate different smoking cessation methods. Revue d'Epidemiologie et de Sante Publique1992;40:187‐90. ">Clavel‐Chapelon 1992</a>; <a href="./references#CD000146-bbs2-0025" title="DaughtonDM , HeatleySA , PrendergastJJ , CauseyD , KnowlesM , RolfCN , et al. Effect of transdermal nicotine delivery as an adjunct to low‐intervention smoking cessation therapy. A randomized, placebo‐controlled, double‐blind study. Archives of Internal Medicine1991;151:749‐52. DaughtonDM , HeatleySA , PrendergastJJ , CauseyD , KnowlesM , RolfCN , et al. Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double‐blind randomized study controlled with placebo [Effetti del rilascio transdermico di nicotina come terapia di supporto per lo svezzamento dal fumo di sigaretta. Uno studio randomizzato in doppio cieco con controlli trattati con placebo.]. Archivio Monaldi1992;47:17‐29. ">Daughton 1991</a>; <a href="./references#CD000146-bbs2-0037" title="FraserD , KobinskyK , SmithSS , KramerJ , TheobaldWE , BakerTB . Five population‐based interventions for smoking cessation: a MOST trial. Translational Behavioral Medicine2014;4(4):382‐90. ">Fraser 2014</a>; <a href="./references#CD000146-bbs2-0046" title="GrahamAL , ChaS , PapandonatosGD , CobbNK , MushroA , FangY , et al. Improving adherence to web‐based cessation programs: a randomized controlled trial study protocol. Trials2013;14:48. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS . Improving adherence to smoking cessation treatment: smoking outcomes in a web‐based randomized trial. Annals of Behavioral Medicine2018;52(4):331‐41. GrahamAL , PapandonatosGD , ChaS , ErarB , AmatoMS , CobbNK , et al. Improving adherence to smoking cessation treatment: Intervention effects in a web‐based randomized trial. Nicotine &amp; Tobacco Research2017;19(3):324‐32. ">Graham 2017</a>; <a href="./references#CD000146-bbs2-0061" title="HuberD . Combined and separate treatment effects of nicotine chewing gum and self‐control method. Pharmacopsychiatry1988;21:461‐2. ">Huber 1988</a>; <a href="./references#CD000146-bbs2-0090" title="NCT00534404 . iQuit Smoking: a randomized trial of internet access to nicotine patches. clinicaltrials.gov/show/NCT00534404 (first received 24 September 2007). ">NCT00534404</a>; <a href="./references#CD000146-bbs2-0098" title="OteroUB , PerezCA , SzkloM , EstevesGA , dePinhoMM , SzkloAS , et al. Randomized clinical trial: effectiveness of the cognitive‐behavioral approach and the use of nicotine replacement transdermal patches for smoking cessation among adults in Rio de Janeiro, Brazil [Ensaio clinico randomizado: efetividade da abordagem cognitivo‐comportamental e uso de adesivos transdermicos de reposicao de nicotina, na cessacao de fumar, em adultos residentes no Municipio do Rio de Janeiro, Brasil]. Cadernos de Saude Publica2006;22:439‐49. ">Otero 2006</a>; <a href="./references#CD000146-bbs2-0099" title="PageAR , WaltersDJ , SchlegelRP , BestJA . Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription. Addictive Behaviors1986;11:443‐6. ">Page 1986</a>; <a href="./references#CD000146-bbs2-0106" title="PuskaP , BjorkqvistS , KoskelaK . Nicotine‐containing chewing gum in smoking cessation: a double blind trial with half year follow‐up. Addictive Behaviors1979;4:141‐6. ">Puska 1979</a>; <a href="./references#CD000146-bbs2-0109" title="RotoP , OjalaA , SundmanK , JokinenK , PeltomaklR . Nicotine gum and withdrawal from smoking. Suomen Laakarllehtl1987;36:3445‐8. ">Roto 1987</a>; <a href="./references#CD000146-bbs2-0126" title="SønderskovJ , OlsenJ , MeillierL , OvervadOK , SabroeS . The effect of transdermal nicotine patches in smoking cessation. A randomized trial in pharmacy customers in Denmark. Ugeskrift for Laeger1999;161:593‐7. SønderskovJ , OlsenJ , SabroeS , MeillierL , OvervadK . Nicotine patches in smoking cessation: A randomized trial among over‐ the‐counter customers in Denmark. American Journal of Epidemiology1997;145:309‐18. ">Sønderskov 1997</a>; <a href="./references#CD000146-bbs2-0128" title="TuiskuA , SalmelaM , NieminenP , ToljamoT . Varenicline and nicotine patch therapies in young adults motivated to quit smoking: a randomized, placebo‐controlled, prospective Studys. Basic &amp; Clinical Pharmacology &amp; Toxicology2016;119(1):78‐84. ">Tuisku 2016</a>; <a href="./references#CD000146-bbs2-0135" title="VillaRS , AlvarezABD , HermidaJRF . Effectiveness of a multicomponent program to quit smoking with and without nicotine chewing gum [Eficacia de un programa multicomponente para dejar de fumar con y sin chicle de nicotina]. Psicologia Conductual1999;7:107‐18. ">Villa 1999</a>; <a href="./references#CD000146-bbs2-0140" title="WisborgK , HenriksenTB , JespersenLB , SecherNJ . Nicotine patches for pregnant smokers: A randomized controlled study. Obstetrics &amp; Gynecology2000;96(6):967‐71. ">Wisborg 2000</a>; <a href="./references#CD000146-bbs2-0141" title="WittchenHU , HochE , KlotscheJ , MuehligS . Smoking cessation in primary care ‐ a randomized controlled trial of bupropion, nicotine replacements, CBT and a minimal intervention. International Journal of Methods in Psychiatric Research2011;20(1):28‐39. ">Wittchen 2011</a>). </p> </section> <section id="CD000146-sec-0057"> <h3 class="title" id="CD000146-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD000146-tbl-0001"><b>Summary of findings for the main comparison</b> Nicotine replacement therapy</a> </p> <section id="CD000146-sec-0058"> <h4 class="title">Any type of NRT versus placebo or no NRT control, six months or longer follow‐up</h4> <p><a href="./references#CD000146-fig-0005" title="">Analysis 1.1</a> included 131 trials (133 comparisons), with over 64,000 participants (<a href="./full#CD000146-tbl-0001">summary of findings Table for the main comparison</a>). A small number of trials contributed to more than one subgroup and two trials were treated as two separate studies in the analyses. Each of the six forms of nicotine replacement therapy (NRT) significantly increased the rate of cessation compared to placebo or no NRT, as did a choice of product. The pooled risk ratio (RR) for abstinence for any form of NRT relative to control was 1.55 (95% confidence interval (CI) 1.49 to 1.61; 64,640 participants). The I<sup>2</sup> statistic was 39%, indicating that little of the variability was attributable to between‐trial differences. The risk ratio and 95% CI for each type are tabulated below. </p> <p> <div class="table" id="CD000146-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of NRT</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>95% CI</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>I²</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N of participants Intervention/Control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40 to 1.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10,596 / 11,985</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.53 to 1.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13,773 / 11,981</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36 to 2.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>490 / 486</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intranasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.49 to 2.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>448 / 439</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablets/lozenges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32 to 1.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2326 / 2113</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oral spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24 to 4.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>318 / 161</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Choice of product</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 to 1.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4179 / 4109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patch and inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 to 1.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>136 / 109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patch and lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01 to 3.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267 / 41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patch and gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.64 to 2.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173 / 86</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patch, gum and lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.00 to 112.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>212 / 212</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>* includes 1 study treated as 2 for analysis; N/A: not applicable</p> </td> </tr> </tbody> </table> </div> </p> <p>Although the estimated effect sizes varied across the different products, confidence intervals were wide for the products with higher estimates which had small numbers of trials. One subgroup based on product type had a confidence interval which did not overlap with the pooled estimate; this group consisted of only one study in which only one participant in the control group had successfully quit smoking (<a href="./references#CD000146-bbs2-0057" title="HeydariG , TalischiF , BatmanghelidjE , PajoohMR , BoroomandA , ZamaniM , et al. Dual addictions, parallel treatments: Nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. La Revue de Santé de la Mediterranée Orientale / al‐Majallah al‐sihhiyah li‐sharq al‐mutawassit (Eastern Mediterranean Health Journal)2013;19(SUPPL 3):S25‐31. ">Heydari 2013</a>). In the tablets/lozenges subgroup, the I<sup>2</sup> statistic was 71%, indicating substantial statistical heterogeneity. In all trials in this subgroup, more participants quit in the intervention arm than in control, but in one study new for this update the point estimate was considerably lower (RR 1.08) (<a href="./references#CD000146-bbs2-0037" title="FraserD , KobinskyK , SmithSS , KramerJ , TheobaldWE , BakerTB . Five population‐based interventions for smoking cessation: a MOST trial. Translational Behavioral Medicine2014;4(4):382‐90. ">Fraser 2014</a>); this study drove the observed statistical heterogeneity. </p> <p>Twelve studies had lower quit rates in the treatment than in the control group at the end of follow‐up (all of which had confidence intervals which crossed the line of no effect), and in a further 73% of trials the 95% confidence interval for the RR included 1 (i.e. the trials did not detect a significant treatment effect). Many of these trials had small numbers of smokers, and hence insufficient power to detect a modest treatment effect with reasonable certainty. One large trial of nicotine patches for people with cardiovascular disease had lower quit rates in the intervention than in the control group (<a href="./references#CD000146-bbs2-0074" title="JosephAM , AntonnucioDO . Lack of efficacy of transdermal nicotine in smoking cessation. New England Journal of Medicine1999;341:1157‐8. JosephAM , NormanSM , FerryLH , ProchazkaAV , WestmanEC , SteeleBG , et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine1996;335:1792‐8. ">Joseph 1996</a>); at six months the quit rates were 14% for active patch and 11% for placebo, but after 48 weeks there had been greater relapse in the active group and rates were 10% and 12% respectively. </p> <p><a href="#CD000146-fig-0003">Figure 3</a> </p> <div class="figure" id="CD000146-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up." data-id="CD000146-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up. </p> </div> </div> </div> <section id="CD000146-sec-0059"> <h5 class="title">Sensitivity to definition of abstinence</h5> <p>For nicotine gum and patch we assessed whether trials that reported sustained abstinence at 12 months had different treatment effects from those that only reported a point prevalence outcome, or had shorter follow‐up (<a href="./references#CD000146-fig-0006" title="">Analysis 2.1</a>; <a href="./references#CD000146-fig-0007" title="">Analysis 2.2</a>). Subgroup categories were sustained abstinence at 12 months or more, sustained abstinence at six months, point prevalence or unclear definition at 12 months, and point prevalence/unclear at six months. For nicotine gum 32/55 studies (56 comparisons) (58%) reported sustained 12‐month abstinence and the estimate was similar to that for all 55 studies: sustained 12‐month RR 1.43, 95% CI 1.31 to 1.56 (13,737 participants), compared with RR 1.49, 95% CI 1.40 to 1.60. The highest estimate was for the subgroup of eight studies reporting sustained abstinence at six months, where confidence intervals did not overlap: RR 2.77, 95% CI 2.14 to 3.59; 4187 participants. This seems to be attributable to one study (<a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a>; <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>), and is unlikely to be of methodological or clinical significance. For nicotine patch, 21/49 studies (43%) reported sustained 12‐month abstinence, and the RR was also similar to that for all 49 studies: sustained 12‐month RR 1.52, 95% CI 1.34 to 1.74 (7622 participants), compared with RR 1.64, 95% CI 1.53 to 1.75 (25,754 participants) overall). For patch studies there was no evidence that the RRs differed significantly between subgroups. </p> </section> <section id="CD000146-sec-0060"> <h5 class="title">Sensitivity to intensity of behavioural support</h5> <p>All trials provided the same behavioural support in terms of advice, counselling, and number of follow‐up visits to the active pharmacotherapy and control groups, but different trials provided different amounts of support. We conducted subgroup analyses by intensity of support for gum and patch trials separately (<a href="./references#CD000146-fig-0008" title="">Analysis 3.1</a>; <a href="./references#CD000146-fig-0009" title="">Analysis 3.2</a>). There was no evidence of a significantly different effect between groups. For nicotine gum the RR was similar across all three subgroups. The control group quit rates varied as expected, averaging 3.5% with low‐intensity support, 9% with high‐intensity individual support and 11.7% with group‐based support. Nicotine patch trials showed the same pattern; the RRs were similar for each subgroup and the average control group quit rates were 9.0% with low‐intensity support, 9.5% with high‐intensity individual support and 17.0% with group‐based support. </p> </section> <section id="CD000146-sec-0061"> <h5 class="title">Sensitivity to treatment settings</h5> <p>We conducted further subgroup analyses for each type of setting in which smokers were recruited or treated (with type of NRT as a subgroup beneath setting). The pooled RR for trials in community volunteers where care was provided in a medical setting was 1.62 (95% CI 1.53 to 1.72, 65 trials, 24,597 participants; <a href="./references#CD000146-fig-0010" title="">Analysis 4.1</a>) and was similar to that of trials conducted in smoking clinics (RR 1.70, 95% CI 1.48 to 1.96, 12 trials, 3300 participants; <a href="./references#CD000146-fig-0011" title="">Analysis 4.2</a>), trials conducted in primary care settings (RR 1.50, 95% CI 1.33 to 1.69, 24 trials, 11,974 participants; <a href="./references#CD000146-fig-0012" title="">Analysis 4.3</a>), trials conducted in hospitals (RR 1.39, 95% CI 1.24 to 1.55, 13 trials, 7037 participants; <a href="./references#CD000146-fig-0013" title="">Analysis 4.4</a>), and trials conducted in settings similar to 'over the counter' (OTC) (RR 1.40, 95% CI 1.26 to 1.55, 9 trials, 13,163 participants; <a href="./references#CD000146-fig-0014" title="">Analysis 4.5</a>). Pooled results from four trials in antenatal clinics were lower than in other settings (RR 1.22, 95% CI 0.92 to 1.62, 1675 participants; <a href="./references#CD000146-fig-0015" title="">Analysis 4.6</a>); this was the only setting in which results did not show a statistically significant effect of the intervention. In a meta‐regression we checked whether there was any evidence of interaction between the treatment setting and type of NRT used. The effect of nicotine gum was highest in the OTC setting and this seems to be attributable to the same study that contributed heterogeneity in the abstinence subgroup analysis above (<a href="./references#CD000146-bbs2-0121" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (2 mg)</a>; <a href="./references#CD000146-bbs2-0122" title="ShiffmanS , FergusonSG , StrahsKR . Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. American Journal of Preventive Medicine2009;36(2):96‐104. ">Shiffman 2009 (4 mg)</a>). </p> <p>Control group quit rates varied by setting; the lowest rates were found in OTC (8.4%) and primary care (6.9%) studies, and the highest rate in smoking clinics (14.3%). Falling within this range, control group rates were 9.3% in antenatal clinics, 12.5% in community volunteers where treatment was provided in a medical setting, and 12.3% in hospitals. </p> </section> <section id="CD000146-sec-0062"> <h5 class="title">Sensitivity to risk of bias and study methods</h5> <p>Excluding those studies at high risk of bias did not significantly alter the point estimate for the main comparison: RR 1.61, 95% CI 1.52 to 1.69, <i>analysis not shown</i> . Similarly, restricting the main analysis to only those 12 studies at low risk of bias across all domains led to results consistent with the main analysis: RR 1.53, 95% CI 1.37 to 1.71, <i>analysis not shown</i> . Removing those studies without biochemical validation did not substantially influence the effect estimate: RR 1.62, 95% CI 1.55 to 1.70, <i>analysis not shown</i> , nor did restricting the analysis to only placebo‐controlled studies: RR 1.61, 95% CI 1.53 to 1.70, <i>analysis not shown</i>. </p> </section> </section> <section id="CD000146-sec-0063"> <h4 class="title">Relapsed smokers</h4> <p>Although many of the trials reported here did not specifically exclude people who had previously tried and failed to quit with NRT, one trial recruited people who had relapsed after patch and behavioural support in an earlier phase of the study but were motivated to make a second attempt (<a href="./references#CD000146-bbs2-0045" title="GourlaySG , ForbesA , MarrinerT , PethicaD , McNeilJJ . Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ1995;311(7001):363‐6. ">Gourlay 1995</a>). This study did not detect an effect on continuous abstinence (RR 1.25, 95% CI 0.34 to 4.60, <i>analysis not shown</i>), although it did detect a significant increase in 28‐day point prevalence abstinence (RR 2.49, 95% CI 1.11 to 5.57). Quit rates were low in both groups with either definition of abstinence. </p> </section> <section id="CD000146-sec-0064"> <h4 class="title">Adverse events</h4> <p>We have made no systematic attempt in this review to synthesize quantitatively the incidence of the various adverse events reported with the different NRT preparations. This was because of the extensive variation in reporting of the nature, timing and duration of symptoms. In the included studies, attrition rates in NRT groups were generally similar to or lower than in control groups. <a href="./appendices#CD000146-sec-0081">Appendix 3</a> summarises the main adverse events reported in the included and excluded studies, where the data were available. </p> <p>The most common adverse events usually reported with nicotine gum include hiccoughs, gastrointestinal disturbances, jaw pain, and orodental problems (<a href="./references#CD000146-bbs2-0278" title="FioreMC , JorenbyDE , BakerTB , KenfordSL . Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA1992;268:2687‐94. ">Fiore 1992</a>; <a href="./references#CD000146-bbs2-0306" title="PalmerKJ , BuckleyMM , FauldsD . Transdermal nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs1992;44:498‐529. ">Palmer 1992</a>). The only adverse event that appears to interfere with use of the patch is skin sensitivity and local skin irritation; this may affect up to 54% of patch users, but it is usually mild and rarely leads to withdrawal of patch use (<a href="./references#CD000146-bbs2-0278" title="FioreMC , JorenbyDE , BakerTB , KenfordSL . Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA1992;268:2687‐94. ">Fiore 1992</a>). The major adverse events reported with the nicotine inhalator and nasal and oral sprays are related to local irritation at the site of administration (mouth and nose respectively). For example, symptoms such as throat irritation, coughing, and oral burning were reported significantly more frequently with participants allocated to the nicotine inhalator than to placebo control (<a href="./references#CD000146-bbs2-0116" title="SchneiderNG , OlmsteadR , NilssonF , ModyFV , FranzonM , DoanK . Efficacy of a nicotine inhaler in smoking cessation: a double‐blind, placebo controlled trial. Addiction1996;91:1293‐306. SchneiderNG , OlmsteadR , NilssonF , ModyFV , FranzonM , DoanK . Efficacy of a nicotine inhaler in smoking cessation: a double‐blind, placebo‐controlled trial [abstract]. Addiction1997;92:630. ">Schneider 1996</a>); none of the experiences, however, were reported as severe. With the nasal spray, nasal irritation and runny nose are the most commonly reported adverse events. In the study of oral spray, hiccoughs and throat irritation were the most commonly reported adverse events (<a href="./references#CD000146-bbs2-0134" title="TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo‐controlled, double blind, multicenter study with 52‐week follow up. Poster Presented at SRNT, Feb 16‐19th, 2011, Toronto, Canada. TønnesenP , LauriH , PerfektR , MannK , BatraA . Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double blind trial. European Respiratory Journal2012;40(3):548‐54. [DOI: 10.1183/09031936.00155811] ">Tønnesen 2012</a>). Nicotine sublingual tablets have been reported to cause hiccoughs, burning and smarting sensation in the mouth, sore throat, coughing, dry lips and mouth ulcers (<a href="./references#CD000146-bbs2-0316" title="WallstromM , SandL , NilssonF , HirschJM . The long‐term effect of nicotine on the oral mucosa. Addiction1999;94:417‐23. ">Wallstrom 1999</a>). Adolescents report similar adverse events to adults (<a href="./references#CD000146-bbs2-0262" title="BaileySR , CrewEE , RiskeEC , AmmermanS , RobinsonTN , KillenJD . Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Paediatric Drugs2012;14(2):91‐108. ">Bailey 2012</a>). </p> <p>A review of adverse events based on 35 trials with over 9000 participants did not find evidence of excess adverse cardiovascular events amongst those assigned to nicotine patch, and the total number of such events was low (<a href="./references#CD000146-bbs2-0280" title="GreenlandS , SatterfieldMH , LanesSF . A meta‐analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety1998;18:297‐308. ">Greenland 1998</a>). A meta‐analysis of adverse events associated with NRT included 92 RCTs and 28 observational studies, and addressed a possible excess of chest pains and heart palpitations among users of NRT compared with placebo groups (<a href="./references#CD000146-bbs2-0297" title="MillsEJ , WuP , LockhartI , WilsonK , EbbertJO . Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta‐analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseases2010;8:8. ">Mills 2010</a>). The authors report an OR of 2.06 (95% CI 1.51 to 2.82) across 12 studies. We replicated this data collection exercise and analysis where data were available (included and excluded) in this review, and detected a similar but slightly lower estimate, OR 1.88 (95% CI 1.37 to 2.57; 15 studies; 11,074 participants; OR rather than RR calculated for comparison; <a href="./references#CD000146-fig-0017" title="">Analysis 6.1</a>). Chest pains and heart palpitations were an extremely rare event, occurring at a rate of 2.5% in the NRT groups compared with 1.4% in the control groups in the 15 trials in which they were reported at all. A recent network meta‐analysis of cardiovascular events associated with smoking cessation pharmacotherapies (<a href="./references#CD000146-bbs2-0298" title="MillsEJ , ThorlundK , EapenS , WuP , ProchaskaJJ . Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta‐analysis. Circulation2014;129(1):28‐41. ">Mills 2014</a>), including 21 RCTs comparing NRT with placebo, found statistically significant evidence that the rate of cardiovascular events with NRT was higher (RR 2.29 95% CI 1.39 to 3.82). However, when only serious adverse cardiac events (myocardial infarction, stroke and cardiovascular death) were considered, the finding was not statistically significant (RR 1.95 95% CI 0.26 to 4.30). A sensitivity analysis demonstrated that lower‐level events, predominantly tachycardia and arrhythmia, accounted for the observed increased risk of cardiovascular events. Chest pains and palpitations are the only clinically significant adverse events to emerge from the trials, and no evidence of significant harm has been identified. </p> <p>When first licensed there was concern about the safety of NRT in smokers with cardiac disease (<a href="./references#CD000146-bbs2-0314" title="Transdermal Nicotine Working Group. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Archives of Internal Medicine1994;154:989‐95. ">TNWG 1994</a>). A trial of nicotine patch that recruited smokers aged over 45 with at least one diagnosis of cardiovascular disease found no evidence that serious adverse events were more common in smokers in the nicotine patch group (<a href="./references#CD000146-bbs2-0074" title="JosephAM , AntonnucioDO . Lack of efficacy of transdermal nicotine in smoking cessation. New England Journal of Medicine1999;341:1157‐8. JosephAM , NormanSM , FerryLH , ProchazkaAV , WestmanEC , SteeleBG , et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine1996;335:1792‐8. ">Joseph 1996</a>). Events related to cardiovascular disease, such as an increase in angina severity, occurred in approximately 16% of participants, but did not differ according to whether or not they were receiving NRT. A review of safety in people with cardiovascular disease found no evidence of an increased risk of cardiac events (<a href="./references#CD000146-bbs2-0290" title="JosephAM , FuSS . Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Progress in Cardiovascular Diseases2003;45:429‐41. ">Joseph 2003</a>). This included data from two randomized trials with short‐term follow‐up that we excluded from the present review (<a href="./references#CD000146-bbs2-0246" title="TzivoniD , KerenA , MeylerS , KhouryZ , LererT , BrunelP . Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovascular Drugs and Therapy1998;12:239‐44. ">Tzivoni 1998</a>; <a href="./references#CD000146-bbs2-0256" title="Working Group for the Study of Transdermal Nicotine. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Archives of Internal Medicine1994;154:989‐95. ">Working Group 1994</a>), and a case‐control study in a population‐based sample. An analysis of 187 smokers admitted to hospital with acute coronary syndromes who received nicotine patches showed no evidence of difference in short‐ or long‐term mortality compared to a propensity‐matched sample of smokers in the same database who did not receive NRT (<a href="./references#CD000146-bbs2-0295" title="MeineTJ , PatelMR , WashamJB , PappasPA , JollisJG . Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. American Journal of Cardiology2005;95:976‐8. ">Meine 2005</a>). A subgroup analysis within a network meta‐analysis of cardiovascular events (<a href="./references#CD000146-bbs2-0298" title="MillsEJ , ThorlundK , EapenS , WuP , ProchaskaJJ . Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta‐analysis. Circulation2014;129(1):28‐41. ">Mills 2014</a>), found no increased risk of cardiovascular events with NRT amongst individuals with predisposing conditions that placed them at an increased risk of having an event (RR 1.24, 95% CI 0.77 to 2.02). Another recent network meta‐analysis in people with cardiovascular disease found a slightly higher number of cardiovascular events with NRT but was not able to draw quantitative conclusions due to the low number of trials reporting adverse events and the variation in adverse event definitions used (<a href="./references#CD000146-bbs2-0313" title="SuissaK , LarivièreJ , EisenbergMJ , EbergM , GoreGC , GradR , et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta‐analysis of randomized controlled trials. Circulation: Cardiovascular Quality and Outcomes2017;10(1):e002458. ">Suissa 2017</a>). </p> <p>The six trials assessing NRT use in pregnant women did not detect significant increases in serious adverse events amongst the treatment groups (<a href="./references#CD000146-bbs2-0006" title="BerlinI , GrangeG , JacobN , TanguyML . Nicotine patches in pregnant smokers: Randomised, placebo controlled, multicentre trial of efficacy. BMJ (online)2014;348:1622. LancasterT . In pregnant smokers, the nicotine patch did not increase abstinence or birthweight more than placebo. Annals of Internal Medicine2014;160(12):JC11. ">Berlin 2014</a>; <a href="./references#CD000146-bbs2-0021" title="BowkerKA , LewisS , ColemanT , VazLR , CooperS . Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(6):895‐8. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK Britton J , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. The New England Journal of Medicine2012;366(9):808‐19. ColemanT , CooperS , ThorntonJG , GraingeMJ , WattsK , BrittonJ , et al. A randomized trial of nicotine‐replacement therapy patches in pregnancy. Obstetrical &amp; Gynecological Survey2012;67(7):387‐8. ColemanT , ThorntonJ , BrittonJ , LewisS , WattsK , CoughtrieMWH , et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: Double‐blind, placebo‐randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research2007;7:2. CooperS , LewisS , ThorntonJG , MarlowN , WattsK , BrittonJ , et al. The SNAP trial: a randomised placebo‐controlled trial of nicotine replacement therapy in pregnancy‐‐clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment (Winchester, England)2014;18(54):1‐128. CooperS , TaggarJ , LewisS , MarlowN , DickinsonA , WhitemoreR , et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow‐up from the randomised, double‐blind, placebo‐controlled SNAP trial [Erratum appears in Lancet Respiratory Medicine. 2014 Nov;2(11):e22]. Lancet Respiratory Medicine2014;2(9):728‐37. EssexHN , ParrottS , WuQ , LiJ , CooperS , ColemanT . Cost‐effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomized controlled trial (SNAP). Nicotine &amp; Tobacco Research2015;17(6):636‐42. GraingeM , ColemanT , CooperS , ThorntonJ , WattsK , BrittonJ , et al. Double‐blind, placebo‐controlled, randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine2011;39:Suppl:172. ThorntonJG , ColemanT , BrittonJ , CooperS , WattsK , LewisS , et al. The smoking, nicotine and pregnancy (SNAP) trial: Main results. Archives of Disease in Childhood: Fetal and Neonatal Edition2011;96:Fa109. VazLR , AveyardP , CooperS , Leonardi‐BeeJ , ColemanT , WattsK , et al. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine &amp; Tobacco Research2016;18(10):1952‐9. VazLR , ColemanT , CooperS , AveyardP , Leonardi‐BeeJ , Snap trial team. The nicotine metabolite ratio in pregnancy measured by trans‐3'‐hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine &amp; Tobacco Research2015;17(11):1318‐23. VazLR , Leonardi‐BeeJ , AveyardP , CooperS , GraingeM , ColemanT . Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy. Nicotine &amp; Tobacco Research2014;16(4):381‐9. ">Coleman 2012</a>; <a href="./references#CD000146-bbs2-0030" title="El‐MohandesAA , WindsorR , TanS , PerryDC , GantzMG , KielyM . A randomized clinical trial of trans‐dermal nicotine replacement in pregnant African‐American smokers. Maternal and Child Health Journal2013;17(5):897‐906. ">El‐Mohandes 2013</a>; <a href="./references#CD000146-bbs2-0096" title="DornelasE , OnckenC , GreeneJ , SankeyHZ , KranzlerHR . Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions2013;22(1):54‐9. FishLJ , PetersonBL , Namenek BrouwerRJ , LynaP , OnckenCA , SwamyG , et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine &amp; Tobacco Research2009;11(5):514‐8. OnckenC , DornelasE , GreeneJ , SankeyH , GlasmannA , FeinnR , et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstetrics &amp; Gynecology2008;112(4):859‐67. SwamyGK , RoelandsJJ , PetersonBL , FishLJ , OnckenCA , PletschP , et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics &amp; Gynecology2009;201(4):354‐7. ">Oncken 2008</a>; <a href="./references#CD000146-bbs2-0104" title="PollakKI , OnckenC , LipkusIM , PetersonBL , SwamyGK , PletschPK , et al. Effectiveness of adding nicotine replacement therapy to cognitive behavioral therapy for smoking cessation in pregnant smokers: the Baby Steps trial (PA6‐3). Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21‐24; Austin, Texas, USA. 2007:25. PollakKI , OnckenCA , LipkusIM , LynaP , SwamyGK , PletschPK , et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. American Journal of Preventive Medicine2007;33:297‐305. ">Pollak 2007</a>; <a href="./references#CD000146-bbs2-0140" title="WisborgK , HenriksenTB , JespersenLB , SecherNJ . Nicotine patches for pregnant smokers: A randomized controlled study. Obstetrics &amp; Gynecology2000;96(6):967‐71. ">Wisborg 2000</a>). The effects of NRT use on neonatal health are discussed further in a separate Cochrane Review, which found no statistically significant differences in rates of any serious adverse events between treatment and control groups (<a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>). As mentioned previously, this separate review covers this topic comprehensively and will be regularly updated, so interested readers should refer to <a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a> for more information on the adverse events profile of NRT in pregnancy. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000146-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000146-sec-0065"></div> <p>This review provides high‐quality evidence from trials including over 64,000 participants that offering nicotine replacement therapy (NRT) to dependent smokers who are prepared to try to quit increases their chance of success over that achieved with the same level of support but without NRT. This applies to all forms of NRT and is independent of any variations in methodology or design characteristics of trials included in the meta‐analysis. In particular we did not find evidence that the relative effect of NRT was smaller in trials with longer follow‐up beyond our six‐month minimum for inclusion. We did not compare end‐of‐treatment risk ratios with post‐treatment follow‐up, and relapse rates may be higher in active treatment participants once they stop using NRT products, but later relapse is probably unrelated to NRT use (<a href="./references#CD000146-bbs2-0274" title="EtterJF , StapletonJA . Nicotine replacement therapy for long‐term smoking cessation: a meta‐analysis. Tobacco Control2006;15:280‐5. ">Etter 2006</a>). </p> <p>The absolute effects of NRT use will depend on the baseline quit rate, which varies in different clinical settings. Studies of people attempting to quit on their own suggest that success rates after six to 12 months are 3% to 5% (<a href="./references#CD000146-bbs2-0285" title="HughesJR , KeelyJ , NaudS . Shape of the relapse curve and long‐term abstinence among untreated smokers. Addiction2004;99:29‐38. ">Hughes 2004</a>). Use of NRT might be expected to increase the rate by 2% to 3%, giving a number needed to treat for an additional beneficial outcome (NNTB) of 56. If, however, the quit rate without pharmacotherapy was estimated to be 15%, either because the population had other predictors of successful quitting or received intensive behavioural support, then another 8% might be expected to quit, giving an NNTB of 11. </p> <section id="CD000146-sec-0066"> <h3 class="title" id="CD000146-sec-0066">Intensity of additional support and treatment setting</h3> <p>We did not detect important differences in relative effect within patch or gum studies by our classification of level of support. A letter prior to the previous update of this review identified inconsistencies in the classification of low‐ and high‐intensity support in this review (<a href="./references#CD000146-bbs2-0319" title="WalshRA , SteadL , LancasterT . The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels &amp; Authors' response. Tobacco Control2007;16:215‐6. ">Walsh 2007</a>). In response, we changed the classification of a small number of trials. This did not alter the conclusion that intensity of support does not appear to be an important moderator of NRT effect. </p> <p>We also did not detect differences in relative effect according to the setting of recruitment and treatment. This subgroup analysis had considerable overlap with the support subgroup since, for example, people recruited in primary care settings typically had lower‐intensity support. </p> <p>There has been continuing debate about the amount of evidence for the efficacy of NRT when obtained OTC without advice or support from a healthcare professional (<a href="./references#CD000146-bbs2-0284" title="HughesJR . The effectiveness of over‐the‐counter nicotine replacement: a rebuttal. Drug and Alcohol Review2001;20:319‐22. ">Hughes 2001</a>; <a href="./references#CD000146-bbs2-0317" title="WalshRA , PenmanAG . The effectiveness of nicotine replacement therapy over‐the‐counter. Drug and Alcohol Review2000;19:243‐7. ">Walsh 2000</a>; <a href="./references#CD000146-bbs2-0318" title="WalshRA , PenmanAG . The effectiveness of over‐the‐counter nicotine replacement: reply to Hughes. Drug and Alcohol Review2001;20:322‐4. ">Walsh 2001</a>). The small number of placebo‐controlled trials in settings intended to replicate OTC settings support the conclusion that the relative effect of NRT is similar to settings where more advice and behavioural support is provided, although quit rates in both control and intervention groups have been low. One other meta‐analysis supports the conclusion of efficacy, although it differs in its inclusion criteria (<a href="./references#CD000146-bbs2-0065" title="HughesJR , NovyP , HatsukamiDK , JensenJ , CallasPW . Efficacy of nicotine patch in smokers with a history of alcoholism. Alcoholism‐Clinical and Experimental Research2003;27:946‐54. ">Hughes 2003</a>). In addition to the same three trials comparing nicotine patch to placebo in an OTC setting (<a href="./references#CD000146-bbs2-0028" title="DavidsonM , EpsteinM , BurtR , SchaeferC , WhitworthG , McDonaldA . Efficacy and safety of an over‐the‐counter transdermal nicotine patch as an aid for smoking cessation. Archives of Family Medicine1998;7:569‐74. ">Davidson 1998</a>; <a href="./references#CD000146-bbs2-0054" title="HaysJT , CroghanGA , OffordKP , HurtRD , SchroederDR , WolterTD , et al. Over‐the‐counter nicotine patch therapy for smoking cessation: Results from randomized, double‐blind, placebo‐controlled and open label trials. American Journal of Public Health1999;89:1701‐7. HaysJT , CroghanGA , OffordKP , WolterTD , NidesMA , DavidsonM . Over‐the‐Counter (OTC) transdermal nicotine patch therapy [abstract]. Journal of Addictive Diseases1997;16:136. HaysJT , CroghanIT , OffordKP , HurtRD , SchroederDR , WolterTD , et al. Over the counter 22mg nicotine patch therapy for smoking cessation: results from randomized double‐blind placebo‐controlled and open label trials. Society for Research on Nicotine and Tobacco 5th Annual Meeting; 1999; San Diego, CA, USA1999. ">Hays 1999</a>; <a href="./references#CD000146-bbs2-0126" title="SønderskovJ , OlsenJ , MeillierL , OvervadOK , SabroeS . The effect of transdermal nicotine patches in smoking cessation. A randomized trial in pharmacy customers in Denmark. Ugeskrift for Laeger1999;161:593‐7. SønderskovJ , OlsenJ , SabroeS , MeillierL , OvervadK . Nicotine patches in smoking cessation: A randomized trial among over‐ the‐counter customers in Denmark. American Journal of Epidemiology1997;145:309‐18. ">Sønderskov 1997</a>), that review includes one study excluded here due to short follow‐up (<a href="./references#CD000146-bbs2-0233" title="FergusonSG , GitchellJG , ShiffmanS . Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction2012;107(7):1349‐53. ShiffmanS , DreslerCM , GorslineJ , DimarinoME . The efficacy of nicotine patch in an over‐the‐counter environment: results from a randomized, double‐blind, placebo‐controlled trial (PO130). 11th World Conference on Tobacco or Health; 2000 August 06‐11; Chicago, Illinois, USA. 2000; Vol. 1. ShiffmanS , GorslineJ , GorodetzkyCW . Efficacy of over‐the‐counter nicotine patch. Nicotine &amp; Tobacco Research2002;4:477‐83. ">Shiffman 2002a</a>). It also pools four trials comparing NRT provided OTC to NRT provided under prescription. We exclude one trial that compared both gum and patch in these settings, but was not randomized (<a href="./references#CD000146-bbs2-0234" title="ShiffmanS , RolfCN , HellebuschSJ , GorslineJ , GorodetzkyCW , ChiangYK , et al. Real‐world efficacy of prescription and over‐the‐counter nicotine replacement therapy. Addiction2002;97:505‐16. ">Shiffman 2002b</a>), and another that has not been published and for which we have been unable to obtain reliable data for inclusion (<a href="./references#CD000146-bbs2-0192" title="KorberlyB , GustavssonG , KruseE . Over‐the‐counter efficacy of a 15 mg daytime nicotine patch for smoking cessation: a randomized multicenter trial. Society for Research on Nicotine and Tobacco 4th European Conference; 2002 October 03‐05; Santander, Spain. 2002:23. KorberlyBH , MaguireMK . An open label multicenter trial to evaluate and compare the efficacy of nicotrol 15mg as part of an OTC intervention package or as a prescription as an aid in smoking cessation. Society for Research on Nicotine and Tobacco Fifth Annual Meeting; 1999;San Diego, CA, USA. 1999. ">Korberly 1999</a>). The abstract reported that there were no significant differences in quit rates between users of nicotine patch who purchased it through a non‐healthcare facility, and those receiving it on prescription. It has also been suggested that the 'real world' effectiveness of NRT declines or disappears once it becomes available to purchase without requiring contact with a health professional who can offer behavioural support and guidance on appropriate use (<a href="./references#CD000146-bbs2-0292" title='KotzD , BrownJ , WestR . Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world". Mayo Clinic Proceedings2014;89(10):1360‐1367. '>Kotz 2014</a>; <a href="./references#CD000146-bbs2-0308" title="PierceJP , GilpinEA . Impact of over‐the‐counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA2002;288:1260‐4. ">Pierce 2002</a>). A comparison of two cross‐sectional surveys in California found that quit rates for self‐selected NRT users were higher than rates for non‐users prior to OTC availability, but after the switch to OTC this difference disappeared (<a href="./references#CD000146-bbs2-0308" title="PierceJP , GilpinEA . Impact of over‐the‐counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA2002;288:1260‐4. ">Pierce 2002</a>). In addition, a prospective cohort study found that the odds of cessation in people who had used OTC NRT were lower than in people who had not used any cessation pharmacotherapy or accessed a national stop‐smoking service (OR 0.69, 95% CI 0.49 to 0.94) (<a href="./references#CD000146-bbs2-0292" title='KotzD , BrownJ , WestR . Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world". Mayo Clinic Proceedings2014;89(10):1360‐1367. '>Kotz 2014</a>). However, these observational studies are at risk of residual confounding from unmeasured confounders, such as psychological factors, as participants self‐selected their treatment. These studies are also at risk of bias, as unaided quit attempts are less likely to be recalled than those involving NRT. </p> <p>A report of a prospective cohort study questioned the effectiveness of NRT outside of the clinical trial setting after finding no difference in relapse rates between smokers trying to quit who used NRT and those who did not use NRT (<a href="./references#CD000146-bbs2-0260" title="AlpertHR , ConnollyGN , BienerL . A prospective cohort study challenging the effectiveness of population‐based medical intervention for smoking cessation. Tobacco Control2012; Vol. 22, issue 1:32‐7. ">Alpert 2012</a>). However, the design of this study has been criticized for not addressing initial quit rates in the two groups (<a href="./references#CD000146-bbs2-0312" title="Stapleton , JA . Perverse conclusion from results. Tobacco Control2012:np. ">Stapleton 2012</a>). Furthermore, two multi‐country prospective cohort studies observed that NRT users had higher quit rates than non‐users (<a href="./references#CD000146-bbs2-0291" title="KaszaKA , HylandAJ , BorlandR , McNeillAD , Bansal‐TraversM , FixBV , et al. Effectiveness of stop‐smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction2012. [DOI: 10.1111/j.1360‐0443.2012.04009.x] ">Kasza 2012</a>; <a href="./references#CD000146-bbs2-0321" title='WestR , ZhouX . Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study. Thorax2007;62:998‐1002. '>West 2007</a>), although in the former study this effect was limited to NRT patches, with no effect detected for oral nicotine products. Again, these are observational studies and are at risk of confounding and bias. </p> </section> <section id="CD000146-sec-0067"> <h3 class="title" id="CD000146-sec-0067">Trials in special populations</h3> <p>Trials generally restricted recruitment to adults over the age of 18; in a small number of trials the age range was not specified. Two relatively small studies in adolescents did not detect an effect of NRT on quitting at six months or longer (<a href="./references#CD000146-bbs2-0087" title="CollinsCC , EpsteinDH , ParzynskiCS , ZimmermanD , MoolchanET , HeishmanSJ . Puffing behavior during the smoking of a single cigarette in tobacco‐dependent adolescents. Nicotine &amp; Tobacco Research2010;12:164‐7. FrankenFH , PickworthWB , EpsteinDH , MoolchanET . Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiology, Biomarkers &amp; Prevention2006;15:154‐7. Jaszyna‐GasiorM , SchroederJR , ThornerED , HeishmanSJ , CollinsCC , LoS , et al. Age at menarche and weight concerns in relation to smoking trajectory and dependence among adolescent girls enrolled in a smoking cessation trial. Addictive Behaviors2009;34(1):92‐5. MoolchanET , RobinsonML , ErnstM , CadetJL , PickworthWB , HeishmanSJ , et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics2005;115(4):e407‐e414. RobinsonML , SchroederJR , MoolchanET . Adolescent smokers screened for a nicotine replacement treatment trial: Correlates of eligibility and enrollment. Nicotine &amp; Tobacco Research2006;8:447‐54. Thorner‐BantugE , Jaszyna‐GasiorM , SchroederJR , CollinsCC , MoolchanET . Weight gain, related concerns, and treatment outcomes among adolescent smokers enrolled in cessation treatment. Journal of the National Medical Association2009;101(10):1009‐14. ">Moolchan 2005</a>; <a href="./references#CD000146-bbs2-0112" title="ScherphofCS , Van denEijndenRJ , EngelsRCME , VolleberghWA . Short‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. Journal of Substance Abuse Treatment2014;46(2):120‐7. ScherphofCS , Van denEijndenRJ , LugtigP , EngelsRCME , VolleberghWA . Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories. Psychopharmacology2014;231(8):1743‐52. ScherphofCS , Van denEijndenRJJM , EngelsRCME , VolleberghWAM . Long‐term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial. Drug and Alcohol Dependence2014;140:217‐20. ">Scherphof 2014</a>). A separate Cochrane Review of tobacco cessation interventions for young people did not detect an effect of NRT, although confidence intervals were wide and did not preclude the possibility of a clinically important effect (<a href="./references#CD000146-bbs2-0277" title="FanshaweTR , HalliwellW , LindsonN , AveyardP , Livingstone‐BanksJ , Hartmann‐Boyce . Tobacco cessation interventions for young people. Cochrane Database of Systematic Reviews2017, Issue 11. [DOI: 10.1002/14651858.CD003289.pub6] ">Fanshawe 2017</a>). This is likely to remain an active area of research. </p> <p>This review previously conducted a separate analysis on a subgroup of studies evaluating NRT in pregnant women. This is covered by a separate Cochrane review (<a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>) which provides more comprehensive analysis of these studies and will be regularly updated (whereas this review is now marked as stable and will no longer be updated). Therefore, readers interested in this topic should refer to (<a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>). </p> </section> <section id="CD000146-sec-0068"> <h3 class="title" id="CD000146-sec-0068">Evidence for differential treatment effects in different subgroups</h3> <p>We made no attempt to conduct separate analyses for any subgroups of trial participants, because subgroup results are uncommon in trial reports, and where data cannot be obtained from all studies there is a risk of bias from using incomplete data. <a href="./references#CD000146-bbs2-0301" title="MunafóM , BradburnM , BowesL , DavidS . Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta‐analysis. Nicotine &amp; Tobacco Research2004;6:769‐76. ">Munafó 2004a</a> has reported the results of a meta‐analysis of nicotine patch by sex. The researchers were able to include data from 11 out of 31 eligible trials (35%) and 36% of study participants. They found no evidence that the nicotine patch was more effective for men than for women, as has been hypothesized; although men showed a somewhat bigger benefit from NRT at 12 months, the difference was not significant. There was also no difference in average placebo quit rates between men and women, which has been reported in some studies. In a commentary some additional data were identified (<a href="./references#CD000146-bbs2-0307" title="PerkinsKA . Obstacles to determining individual differences in the efficacy of smoking cessation medications. Nicotine &amp; Tobacco Research2004;6:765‐7. ">Perkins 2004</a>), but this did not alter the conclusions (<a href="./references#CD000146-bbs2-0302" title="MunafóM , BradburnM , BowesL , DavidS . Investigating subgroups in smoking cessation treatment response: Response to Perkins. Nicotine &amp; Tobacco Research2004;6:865‐7. ">Munafó 2004b</a>). A second meta‐analysis of any type of NRT reported that in women the odds ratio for cessation declined with increasing length of follow‐up, with a non‐significant difference at 12 months (<a href="./references#CD000146-bbs2-0266" title="Cepeda‐BenitoA , ReynosoJT , ErathS . Meta‐analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. Journal of Consulting and Clinical Psychology2004;72:712‐22. ">Cepeda‐Benito 2004</a>). Amongst men the odds ratio declined less over time and remained significant. Based on a further subgroup analysis, they also reported that the decline in long‐term efficacy in women was greater in trials with low‐intensity support than with high‐intensity support, suggesting that the more intensive support helped prevent late relapse in women who had initially received NRT. Although there was no evidence of bias, the review could only include a subset of published studies, so the finding should be regarded as hypothesis‐generating. All review authors agreed that trials are underpowered to identify any interaction between treatment and any type of individual characteristics, and recommended public archiving of data from studies, as well as new research specifically designed to test group‐by‐treatment interactions. At the moment there does not appear to be sufficient evidence of clinically important differences between men and women to guide treatment matching. </p> </section> <section id="CD000146-sec-0069"> <h3 class="title" id="CD000146-sec-0069">Re‐treating relapsed smokers</h3> <p>Whilst end‐of‐treatment success rates may be quite high, many people relapse after the end of therapy. There is suggestive evidence that repeated use of NRT in people who have relapsed after an initial course may produce further quitters, although the absolute effect is small (<a href="./references#CD000146-bbs2-0045" title="GourlaySG , ForbesA , MarrinerT , PethicaD , McNeilJJ . Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ1995;311(7001):363‐6. ">Gourlay 1995</a>). A subgroup analysis in another trial indicated that the relative effect of treatment with nicotine patch compared to placebo was at least as high for people who had used NRT before (<a href="./references#CD000146-bbs2-0073" title="DurcanMJ , WhiteJ , JorenbyDE , FioreMC , RennardSI , LeischowSJ , et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. American Journal of Health Behaviors2002;26:213‐20. JamersonBD , NidesM , JorenbyDE , DonahueR , GarrettP , JohnstonJA , et al. Late‐term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clinical Therapeutics2001;23:744‐52. JorenbyDE , LeischowSJ , NidesMA , RennardSI , JohnstonJA , HughesAR , et al. A controlled trial of sustained‐release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine1999;340:685‐91. ">Jorenby 1999</a>, reported in <a href="./references#CD000146-bbs2-0273" title="DurcanMJ , WhiteJ , JorenbyDE , FioreMC , RennardSI , LeischowSJ , et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. American Journal of Health Behaviors2002;26:213‐20. ">Durcan 2002</a>). The authors noted that there was no way to distinguish between people who had completely failed to quit using NRT and those who had been initially successful but relapsed. </p> </section> <section id="CD000146-sec-0070"> <h3 class="title" id="CD000146-sec-0070">Limitations of the evidence base</h3> <p>Two possible limitations to this evidence base need to be borne in mind: risk of bias in individual studies and publication bias. For the former, although we judged most of our included studies to be at unclear or high risk of bias in at least one domain, restricting the analysis to only those studies at low risk of bias overall did not significantly alter the pooled effect. For the latter, we tried to partly address any shortcomings from having limited our analysis to reported data by approaching investigators, where necessary, to obtain additional unpublished data or to clarify areas of uncertainty. Although we took steps to minimize publication bias by writing to the manufacturers of NRT products when this review was first prepared, the response was poor and we have not repeated this exercise, although we have searched clinical trials registries. It is therefore possible that there are some unpublished trials, with less favourable results, that we have not identified despite our efforts to do so. A funnel plot (<a href="#CD000146-fig-0004">Figure 4</a>) shows some evidence of asymmetry for trials in the main comparison; however, given the large number of trials in the review, the funnel plot does not suggest that results would be altered significantly were smaller studies with lower RRs included. A meta‐analysis has also demonstrated that nicotine gum and patch studies that received pharmaceutical industry funding have on average slightly higher effect sizes than other studies after controlling for some trial characteristics (<a href="./references#CD000146-bbs2-0275" title="EtterJF , BurriM , StapletonJ . The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta‐analysis (PA9‐6). Addiction2007;102:815‐22. ">Etter 2007</a>). The practical effect of these considerations is that the magnitude of the effectiveness of NRT may be smaller than our estimates suggest. </p> <div class="figure" id="CD000146-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up." data-id="CD000146-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up. </p> </div> </div> </div> <p>A possible further limitation relates to length of follow‐up. This review excludes studies with less than a six‐month follow‐up from the start of treatment; the outcome used reflects the effect of NRT after the end of active treatment. A comparison of abstinence rates during treatment and abstinence at one year suggests that the relative effect of NRT declines once active therapy stops (<a href="./references#CD000146-bbs2-0276" title="FagerströmKO . Clinical treatment of tobacco dependence: The endurance of pharmacologic efficacy. Journal of Clinical Psychiatry Monograph2003;18:35‐40. ">Fagerström 2003</a>), i.e. people who quit with the help of NRT are a little more likely to relapse after they discontinue treatment than those on placebo. The relative effect of NRT could continue to decline even after a year of follow‐up. However, a meta‐analysis comparing one‐year and long‐term outcomes in 12 NRT trials with follow‐up beyond one year suggested that the relative efficacy did not change, with similar relapse rates in the active and placebo groups, but further relapse does reduce the absolute difference in quit rates (<a href="./references#CD000146-bbs2-0274" title="EtterJF , StapletonJA . Nicotine replacement therapy for long‐term smoking cessation: a meta‐analysis. Tobacco Control2006;15:280‐5. ">Etter 2006</a>). </p> </section> <section id="CD000146-sec-0071"> <h3 class="title" id="CD000146-sec-0071">Stability of the evidence base</h3> <p>This review was first published in 1996. Despite the number of included studies more than doubling over this time, the effect estimate has remained remarkably stable, and our intention is that this publication is the final time the Cochrane Tobacco Addiction Group will review the evidence comparing NRT to placebo or to no pharmacotherapy. This is not to say that all questions about NRT have been answered; evidence is still needed comparing different forms, doses, and durations of NRT, comparing NRT to other pharmacotherapies, and testing NRT in special populations where we may reasonably hypothesize that its effectiveness differs from that in the general population (e.g. pregnant women, adolescents). Further studies are also needed of electronic cigarettes containing nicotine, which some consider a form of NRT (but which we have never included in this review). However, we will cover these in separate reviews which we will continue to update regularly (<a href="./references#CD000146-bbs2-0264" title="CahillK , Lindson‐HawleyN , ThomasKH , FanshaweTR , LancasterT . Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD006103.pub7] ">Cahill 2016</a>; <a href="./references#CD000146-bbs2-0268" title="ColemanT , ChamberlainC , DaveyM , CooperSE , Leonardi‐BeeJ . Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2] ">Coleman 2015</a>; <a href="./references#CD000146-bbs2-0277" title="FanshaweTR , HalliwellW , LindsonN , AveyardP , Livingstone‐BanksJ , Hartmann‐Boyce . Tobacco cessation interventions for young people. Cochrane Database of Systematic Reviews2017, Issue 11. [DOI: 10.1002/14651858.CD003289.pub6] ">Fanshawe 2017</a>; <a href="./references#CD000146-bbs2-0281" title="Hartmann‐BoyceJ , McRobbieH , BullenC , BeghR , SteadLF , HajekP . Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD010216.pub3] ">Hartmann‐Boyce 2016</a>; <a href="./references#CD000146-bbs2-0286" title="HughesJR , SteadLF , Hartmann‐BoyceJ , CahillK , LancasterT . Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4] ">Hughes 2014</a>). In summary, based on 20 years of research and 136 randomized controlled trials in over 64,000 participants, we believe the question of whether NRT helps people to quit smoking to be definitively answered. We consider that further research is highly unlikely to change our confidence in the effect of NRT, and funders and researchers should give careful thought before pursuing further studies comparing established forms of NRT with control. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000146-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for most recent update" data-id="CD000146-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for most recent update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000146-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up." data-id="CD000146-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up." data-id="CD000146-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any type of NRT versus placebo/no NRT control, outcome: 1.1 Smoking cessation at 6+ months follow up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any type of NRT versus placebo/no NRT control, Outcome 1 Smoking cessation at 6+ months follow up." data-id="CD000146-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Any type of NRT versus placebo/no NRT control, Outcome 1 Smoking cessation at 6+ months follow up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup: Definition of abstinence, Outcome 1 Nicotine gum. Smoking cessation." data-id="CD000146-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Subgroup: Definition of abstinence, Outcome 1 Nicotine gum. Smoking cessation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup: Definition of abstinence, Outcome 2 Nicotine patch: Smoking cessation." data-id="CD000146-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Subgroup: Definition of abstinence, Outcome 2 Nicotine patch: Smoking cessation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup: Level of behavioural support, Outcome 1 Nicotine gum. Smoking cessation." data-id="CD000146-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Subgroup: Level of behavioural support, Outcome 1 Nicotine gum. Smoking cessation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup: Level of behavioural support, Outcome 2 Nicotine patch. Smoking cessation." data-id="CD000146-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Subgroup: Level of behavioural support, Outcome 2 Nicotine patch. Smoking cessation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 1 Community volunteer (treatment provided in medical setting)." data-id="CD000146-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 1 Community volunteer (treatment provided in medical setting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 2 Smoking clinic." data-id="CD000146-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 2 Smoking clinic.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 3 Primary care." data-id="CD000146-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 3 Primary care.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 4 Hospitals." data-id="CD000146-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 4 Hospitals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 5 Community volunteer (treatment provided in 'over‐the‐counter' setting)." data-id="CD000146-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 5 Community volunteer (treatment provided in 'over‐the‐counter' setting). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 6 Antenatal clinic." data-id="CD000146-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Subgroup: Recruitment/treatment setting, Outcome 6 Antenatal clinic.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 NRT in pregnancy, Outcome 1 Smoking cessation." data-id="CD000146-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 NRT in pregnancy, Outcome 1 Smoking cessation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000146-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/urn:x-wiley:14651858:media:CD000146:CD000146-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_t/tCD000146-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Palpitations in NRT vs placebo users, Outcome 1 Palpitations/chest pains." data-id="CD000146-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Palpitations in NRT vs placebo users, Outcome 1 Palpitations/chest pains.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/media/CDSR/CD000146/image_n/nCD000146-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000146-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nicotine replacement therapy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Nicotine replacement therapy versus control for smoking cessation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people who smoke cigarettes<br/> <b>Settings:</b> clinical and non‐clinical, including over the counter<br/> <b>Intervention:</b> nicotine replacement therapy of any form </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Nicotine replacement therapy of any form</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Smoking cessation at 6+ months follow‐up</b><br/> Follow‐up: 6 to 24 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 1.55</b> <br/> (1.49 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>64,640<br/> (133 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>162 per 1000</b><br/> (156 to 168) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Limited behavioural support</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b><br/> (60 to 64) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Intensive behavioural support</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>232 per 1000</b><br/> (224 to 242) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Most studies are judged to be at unclear or high risk of bias, but restricting to only studies at low risk of bias did not significantly alter the effect.<br/> <sup>2</sup>There are likely to be some unpublished trials with less favourable results that we were unable to identify, and a funnel plot showed some evidence of asymmetry. However, given the large number of trials in the review, this does not suggest the results would be altered significantly were smaller studies with lower RRs included. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Nicotine replacement therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000146-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Nicotine replacement therapies available in the UK</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Available doses</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine transdermal patches</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Worn over 16 hours: 5 mg, 10 mg, 15 mg, 25 mg doses<br/> Worn over 24 hours: 7 mg, 14 mg, 20 mg, 21 mg, 30 mg doses* </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine chewing gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mg and 4 mg doses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine sublingual tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 mg dose</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 mg, 1.5 mg, 2 mg and 4 mg doses</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine inhalation cartridge plus mouthpiece</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cartridge containing 10 mg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine metered nasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg dose/spray</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nicotine oral spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 mg dose/spray</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>Information extracted from British National Formulary</p> <p>* 35 mg/24‐hour and 53.5 mg/24‐hour patches available in other regions.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Nicotine replacement therapies available in the UK</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/full#CD000146-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any type of NRT versus placebo/no NRT control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Smoking cessation at 6+ months follow up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.49, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.40, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [1.53, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [1.36, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Intranasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>887</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [1.49, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Tablets/lozenges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.32, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Oral spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.48 [1.24, 4.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Choice of NRT product</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.25, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Patch and inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.57, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9 Patch and lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [1.01, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10 Patch and gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.64, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11 Patch, gum and lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.0 [2.00, 112.54]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any type of NRT versus placebo/no NRT control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup: Definition of abstinence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nicotine gum. Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.40, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sustained 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.31, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Sustained 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.77 [2.14, 3.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 PP/uncertain 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [1.12, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 PP/uncertain 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.20, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nicotine patch: Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.52, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Sustained 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.34, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Sustained 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [1.51, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 PP/uncertain 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.44, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 PP/uncertain 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [1.32, 2.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup: Definition of abstinence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup: Level of behavioural support</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nicotine gum. Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21759</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.40, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low intensity support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.46, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High intensity individual support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [1.18, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 High intensity group‐based support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.40, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nicotine patch. Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23657</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [1.56, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low intensity support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [1.54, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High intensity individual support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.47, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 High intensity group‐based support</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3638</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.43, 1.90]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup: Level of behavioural support</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup: Recruitment/treatment setting</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Community volunteer (treatment provided in medical setting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.53, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.28, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [1.59, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Nicotine inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.98, 3.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Nicotine tablet/lozenge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [1.61, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Nicotine intranasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.16, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Combination of NRT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [1.01, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Nicotine oral spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.48 [1.24, 4.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Smoking clinic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [1.48, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.30, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Nicotine inhalator</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [1.30, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Nicotine intranasal spray</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>475</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [1.44, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.18, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Primary care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.33, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.35, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.15, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Choice of NRT products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.83, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Hospitals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7037</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.24, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.86, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2492</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.10, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Combination of NRT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.64, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Choice of NRT products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2025</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.36, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Community volunteer (treatment provided in 'over‐the‐counter' setting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.26, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3297</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.79 [2.60, 5.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [1.38, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Tablets/lozenges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1034</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.89, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Choice of product</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [1.03, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Antenatal clinic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.92, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Nicotine gum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.50, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Nicotine patch</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.85, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Choice of NRT products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.69, 3.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup: Recruitment/treatment setting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">NRT in pregnancy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abstinence at end of pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [1.04, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Abstinence at longest post partum follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.90, 1.86]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">NRT in pregnancy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000146-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Palpitations in NRT vs placebo users</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Palpitations/chest pains <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [1.37, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Palpitations in NRT vs placebo users</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000146.pub5/references#CD000146-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000146.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000146-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000146-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000146-note-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000146-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000146-note-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD000146-note-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD000146-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD000146-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000146-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000146-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000146\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000146\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000146\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000146\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000146\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=STpJR8yz&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000146.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000146.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000146.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000146.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000146.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714554375"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000146.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714554379"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000146.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d717d1c08937f',t:'MTc0MDcxNDU1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 